This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disturbances of smell and taste
R18_DISTU_SMELL_TASTE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1729 |
4. Check minimum number of eventsNone |
1729 |
5. Include endpointsNone |
1729 |
6. Filter based on genotype QC (FinnGen only) |
1686 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R4[0-6]
- Name in latin
- Dysfunctiones olfactus
Similar endpoints
↥List of similar endpoints to
Disturbances of smell and taste
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving cognition, perception, emotional state and behaviour
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1686 | 1168 | 518 |
| Unadjusted period prevalence (%) | 0.36 | 0.41 | 0.24 |
| Median age at first event (years) | 57.47 | 56.84 | 58.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1729
- Matched controls
- 17290
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R43.8
ICD-10 Finland
Other and unspecified disturbances of smell and taste
834.8
307.7
600
11
R43.0
ICD-10 Finland
Anosmia
3918.4
307.7
1064
7
R43.1
ICD-10 Finland
Parosmia
571.5
208.6
203
*
R42
ICD-10 Finland
Dizziness and giddiness
5.2
178.3
445
1073
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.3
126.9
285
617
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.7
100.2
169
277
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.0
77.8
251
711
R01AD09
ATC
mometasone; nasal
2.5
75.0
1000
6108
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
6.4
74.0
127
211
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
72.8
236
670
R01AD08
ATC
fluticasone; nasal
2.4
63.9
659
3519
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.9
58.0
132
284
R43
ICD-10 Finland
Disturbances of smell and taste
257.3
49.3
50
*
N16
ICPC
Disturbance of smell/taste
134.0
49.1
52
*
R01AD12
ATC
fluticasone furoate; nasal
2.1
48.2
676
3996
R43.2
ICD-10 Finland
Parageusia
+∞
42.9
41
*
J31.0
ICD-10 Finland
Chronic rhinitis
2.9
42.2
223
845
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
38.3
579
3454
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
34.3
675
4369
UDM02
NOMESCO Finland
Sinoscopy
4.8
32.4
74
159
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
44.3
31.9
39
9
R41.0
ICD-10 Finland
Disorientation, unspecified
12.6
31.6
31
25
R01AD58
ATC
fluticasone, combinations; nasal
1.9
31.4
507
3058
A02BC05
ATC
esomeprazole; systemic
1.8
30.7
765
5276
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.6
30.5
186
755
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
30.5
531
3277
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
30.2
442
2572
G44.2
ICD-10 Finland
Tension-type headache
2.2
30.1
277
1355
AA1AD
NOMESCO Finland
CT of head and brain
1.9
28.4
468
2826
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.8
26.4
136
505
H02AB06
ATC
prednisolone; systemic
1.7
25.6
853
6282
N02AX02
ATC
tramadol; systemic, rectal
1.7
25.6
763
5454
J33.8
ICD-10 Finland
Other polyp of sinus
4.8
25.3
58
125
M54.5
ICD-10 Finland
Low back pain
1.7
25.1
669
4630
R53
ICD-10 Finland
Malaise and fatigue
1.8
23.3
426
2635
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.8
22.8
119
445
S06.3
ICD-10 Finland
Focal brain injury
6.3
21.5
36
58
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
19.2
21.3
32
17
R41.3
ICD-10 Finland
Other amnesia
6.2
21.1
36
59
N06AX11
ATC
mirtazapine; oral
1.7
20.2
589
4117
N06AB10
ATC
escitalopram; oral
1.8
20.1
348
2107
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
20.1
425
2728
A02BC02
ATC
pantoprazole; systemic
1.7
19.9
1207
10072
R51.80
ICD-10 Finland
Headache
1.9
19.8
275
1552
N03AX16
ATC
[U] pregabalin
1.7
19.4
401
2552
A02BC03
ATC
lansoprazole; oral
1.7
19.2
506
3438
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.7
19.2
109
426
UJF32
NOMESCO Finland
Coloscopy
1.7
19.0
461
3063
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
19.0
211
1100
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
19.0
474
3175
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
18.9
142
633
R06AX27
ATC
desloratadine; oral
1.7
18.8
520
3574
M01AH05
ATC
etoricoxib; oral
1.6
18.8
1125
9282
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
18.4
339
2085
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
18.4
74
239
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.5
18.0
63
186
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
17.9
210
1115
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
17.9
531
3705
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.7
17.8
33
59
Z01.2
ICD-10 Finland
Dental examination
1.6
17.6
819
6340
L01
ICPC
Neck symptom/complaint
1.8
17.3
307
1863
J01AA02
ATC
doxycycline; systemic
1.7
17.3
1356
11812
P20
ICPC
Memory disturbance
2.0
16.7
200
1069
N17
ICPC
Vertigo/dizziness
2.0
16.7
211
1149
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
16.7
141
660
M79.6
ICD-10 Finland
Pain in limb
1.5
16.4
775
5989
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
16.3
128
582
K30
ICD-10 Finland
Functional dyspepsia
1.9
16.2
217
1205
M03BX02
ATC
tizanidine; oral
1.5
16.1
1082
8998
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
16.0
199
1077
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.2
16.0
65
211
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
16.0
760
5871
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
15.8
889
7106
R51.81
ICD-10 Finland
Facial pain NOS
3.4
15.7
57
173
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.9
15.6
219
1234
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
15.5
181
958
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
15.5
395
2641
R03AC02
ATC
salbutamol; inhalant
1.5
15.4
940
7627
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
15.2
704
5388
K59.0
ICD-10 Finland
Constipation
2.5
15.2
96
395
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.2
1553
14193
L03
ICPC
Low back symptom/complaint
1.6
15.0
511
3657
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.9
14.9
206
1155
M01AE02
ATC
naproxen; oral, rectal
1.5
14.9
959
7846
N03AX12
ATC
[U] gabapentin; oral
1.7
14.9
276
1693
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
14.8
76
282
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
14.7
233
1364
AA1CG, ,
SPAT
5.2
14.6
30
59
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
14.6
57
181
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
14.4
434
3014
C07AA05
ATC
propranolol; systemic
1.7
14.4
338
2208
R01AD11
ATC
triamcinolone; nasal
2.0
14.2
165
873
N06AX21
ATC
duloxetine; oral
1.9
14.1
207
1183
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.9
13.9
175
950
R02
ICPC
Shortness of breath/dyspnoea
1.8
13.9
229
1355
S06.0
ICD-10 Finland
Concussion
1.9
13.7
172
933
J02AC01
ATC
fluconazole; systemic
1.5
13.6
687
5318
A04
ICPC
Weakness/tiredness general
1.8
13.6
246
1496
R52.9
ICD-10 Finland
Pain, unspecified
1.9
13.6
179
988
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.1
13.5
134
668
J34.2
ICD-10 Finland
Deviated nasal septum
2.3
13.5
99
437
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
13.4
220
1300
P76
ICPC
Depressive disorder
2.2
13.2
113
533
N05AH04
ATC
quetiapine; oral
1.7
13.0
262
1640
G20
ICD-10 Finland
Parkinson disease
3.0
13.0
57
194
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
13.0
127
630
G43.9
ICD-10 Finland
Migraine, unspecified
2.3
13.0
104
477
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
12.8
595
4515
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
12.8
767
6118
R07.0
ICD-10 Finland
Pain in throat
2.1
12.8
124
614
R03BA08
ATC
ciclesonide; inhalant
1.9
12.6
164
901
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.8
12.5
62
226
H93.1
ICD-10 Finland
Tinnitus
2.1
12.5
129
653
J01FA10
ATC
azithromycin; systemic
1.4
12.5
963
8039
R21
ICPC
Throat symptom/complaint
1.6
12.5
333
2239
M25.5
ICD-10 Finland
Pain in joint
1.5
12.5
578
4381
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
12.4
174
979
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.4
721
5709
L17
ICPC
Foot/toe symptom/complaint
1.5
12.2
518
3852
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.5
12.1
76
312
N06AX16
ATC
venlafaxine; oral
1.7
12.1
237
1471
H81.3
ICD-10 Finland
Other peripheral vertigo
3.4
12.1
43
129
L08
ICPC
Shoulder symptom/complaint
1.5
12.1
405
2867
N05BA04
ATC
oxazepam; oral
1.5
12.0
409
2905
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
11.9
98
455
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
11.8
230
1427
UDC00
NOMESCO Finland
Ear microscopy
2.0
11.7
123
628
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
11.6
162
909
R06.0
ICD-10 Finland
Dyspnoea
1.5
11.6
437
3167
K80
ICPC
Cardiac arrhythmia NOS
1.9
11.6
154
851
R25.1
ICD-10 Finland
Tremor, unspecified
2.8
11.6
56
202
N06AX22
ATC
agomelatine; oral
3.3
11.5
43
133
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
11.4
445
3247
R13
ICD-10 Finland
Dysphagia
2.0
11.4
123
634
Z01.7
ICD-10 Finland
Laboratory examination
1.6
11.3
287
1903
M02AA07
ATC
piroxicam; topical
1.4
11.2
585
4514
D07AC01
ATC
betamethasone; topical
1.4
11.0
597
4640
A11
ICPC
Chest pain NOS
1.9
11.0
144
793
D01
ICPC
Abdominal pain/cramps general
1.7
10.9
206
1266
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
10.8
281
1873
S06.2
ICD-10 Finland
Diffuse brain injury
5.2
10.8
22
43
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.6
10.8
269
1775
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
10.7
95
454
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
10.7
162
934
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.7
673
5366
M01AB05
ATC
diclofenac; systemic, rectal
1.4
10.6
1103
9577
H02
ICPC
Hearing complaint
1.6
10.6
241
1553
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
10.6
914
7685
R05
ICPC
Cough
1.5
10.5
423
3100
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
10.5
342
2399
R05
ICD-10 Finland
Cough
1.5
10.5
364
2588
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
10.4
1106
9626
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
10.3
127
685
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
10.3
85
395
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
10.3
1196
10563
SFA10
NOMESCO Finland
One-surface restoration
1.4
10.3
909
7661
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
10.1
573
4470
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
10.1
799
6599
L12
ICPC
Hand/finger symptom/complaint
1.6
10.1
287
1950
J01FA09
ATC
clarithromycin; systemic
1.4
10.1
511
3908
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
10.0
589
4625
XA800
NOMESCO Finland
Neuropsychological investigation
2.6
10.0
58
230
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
10.0
209
1318
R03DC03
ATC
montelukast; oral
1.6
10.0
274
1848
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
9.9
161
946
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
9.9
368
2648
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
9.9
139
782
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
9.9
300
2068
G43.3
ICD-10 Finland
Complicated migraine
3.4
9.9
35
105
H02AB04
ATC
methylprednisolone; systemic
1.6
9.8
230
1492
N06AX26
ATC
vortioxetine; oral
2.0
9.8
111
581
J01DB01
ATC
cefalexin; oral
1.5
9.8
1375
12506
L02
ICPC
Back symptom/complaint
1.7
9.7
176
1067
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
9.7
142
809
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
9.7
155
907
P03
ICPC
Feeling depressed
1.8
9.7
145
833
S29
ICPC
Skin symptom/complaint other
1.5
9.7
339
2411
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
9.6
98
495
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
2.3
9.5
73
329
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
9.5
101
517
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
9.5
453
3419
N06AB04
ATC
citalopram; systemic
1.5
9.5
312
2188
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.2
9.5
81
382
H81.0
ICD-10 Finland
Ménière disease
3.3
9.5
35
108
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
9.4
340
2433
N06AA09
ATC
amitriptyline; systemic
1.8
9.3
151
889
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
9.3
128
717
M54.2
ICD-10 Finland
Cervicalgia
1.8
9.2
139
799
M54.3
ICD-10 Finland
Sciatica
2.0
9.2
101
523
EB1VA, ,
NOMESCO Finland
1.5
9.2
305
2140
SPAT1053
SPAT
Memory test
1.7
9.2
176
1083
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
9.2
92
461
I95.1
ICD-10 Finland
Orthostatic hypotension
2.8
9.2
44
158
R35
ICD-10 Finland
Polyuria
2.0
9.2
99
510
R01AD59
ATC
mometasone, combinations; nasal
1.9
9.2
116
631
D11
ICPC
Diarrhoea
1.7
9.2
187
1171
UKC02
NOMESCO Finland
Cystoscopy
1.6
9.1
209
1348
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.6
9.1
53
211
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
9.1
147
864
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
9.1
244
1636
S18
ICPC
Laceration/cut
1.4
9.1
773
6428
N89
ICPC
Migraine
2.5
8.9
57
237
M79.1
ICD-10 Finland
Myalgia
1.6
8.9
243
1633
R01AD05
ATC
budesonide; nasal
1.8
8.9
130
740
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
8.9
432
3266
G04BD12
ATC
mirabegron; oral
1.6
8.9
193
1228
A06AC51
ATC
ispaghula, combinations; oral
2.1
8.9
78
372
N04BC05
ATC
pramipexole; oral
1.8
8.9
125
704
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
8.9
328
2355
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
8.8
139
810
XF402
NOMESCO Finland
ECG with work load test
1.7
8.8
154
926
XKD00
NOMESCO Finland
Uroflowmetry
1.7
8.7
176
1099
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
8.6
464
3569
J05AB11
ATC
valaciclovir; oral
1.6
8.6
245
1663
G50.1
ICD-10 Finland
Atypical facial pain
3.1
8.6
35
115
TAB00
NOMESCO Finland
Lumbar puncture
2.3
8.5
64
287
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
8.5
162
997
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
8.5
161
990
N02BF01
ATC
gabapentin; oral
1.7
8.5
175
1100
P06
ICPC
Sleep disturbance
1.6
8.4
203
1326
J01FA06
ATC
roxithromycin; oral
1.4
8.4
632
5137
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
8.4
738
6144
J33.9
ICD-10 Finland
Nasal polyp, unspecified
3.4
8.4
29
86
N06AX12
ATC
bupropion; oral
1.9
8.3
101
543
R74
ICPC
Upper respiratory infection acute
1.4
8.2
510
4013
J01CA04
ATC
amoxicillin; systemic
1.4
8.2
1349
12346
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.6
8.2
45
174
L13
ICPC
Hip symptom/complaint
1.5
8.2
334
2440
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.2
689
5689
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.1
469
3646
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
8.1
60
267
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
8.1
149
908
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
8.1
847
7223
R07.3
ICD-10 Finland
Other chest pain
1.7
8.1
162
1011
L57.0
ICD-10 Finland
Actinic keratosis
1.6
8.0
170
1075
R39.1
ICD-10 Finland
Other difficulties with micturition
2.5
8.0
48
194
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
8.0
703
5837
Z2221
NOMESCO Finland
Medical doctor
1.4
8.0
410
3123
R83
ICPC
Respiratory infection other
1.4
8.0
386
2911
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
7.9
102
559
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
4.5
7.9
19
43
N06AB06
ATC
sertraline; oral
1.6
7.9
168
1064
G04CA02
ATC
tamsulosin; oral
1.5
7.9
251
1745
L28
ICPC
Limited function/disability (L)
1.5
7.9
277
1966
F06.7
ICD-10 Finland
Mild cognitive disorder
2.8
7.8
38
138
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.0
7.8
82
419
H57.1
ICD-10 Finland
Ocular pain
2.2
7.8
63
291
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
7.8
296
2132
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.8
282
2012
SFA20
NOMESCO Finland
Two-surface restoration
1.3
7.8
954
8303
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.6
7.7
42
162
SPAT1043
SPAT
Audiometry
1.7
7.7
149
920
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.7
781
6611
N03AX11
ATC
topiramate; oral
2.7
7.7
40
151
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
7.7
156
977
R06AE07
ATC
cetirizine; oral
1.3
7.7
709
5922
A97
ICPC
No disease
1.5
7.6
311
2271
R52.2
ICD-10 Finland
Other chronic pain
2.2
7.6
64
301
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.6
229
1574
G47.3
ICD-10 Finland
Sleep apnoea
1.4
7.6
352
2633
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
7.6
196
1302
DFF59
NOMESCO Finland
Other assessment of balance
8.9
7.5
15
17
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.5
528
4228
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
7.5
273
1949
N06AB03
ATC
fluoxetine; oral
1.6
7.5
191
1263
A02BC04
ATC
rabeprazole; oral
1.7
7.5
151
944
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.3
7.4
55
245
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
7.4
169
1088
M75.8
ICD-10 Finland
Other shoulder lesions
2.1
7.4
68
331
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.1
7.4
66
318
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
7.4
227
1566
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
7.4
232
1608
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
7.4
269
1922
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
7.3
429
3334
S02.11
ICD-10 Finland
Fracture of base of skull, open
10.9
7.3
13
12
A02BA02
ATC
ranitidine; systemic
1.5
7.2
277
1997
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
7.2
1173
10576
R51
ICD-10 Finland
Headache
1.9
7.2
84
446
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
7.2
117
689
A01AB09
ATC
miconazole; local oral
1.7
7.2
130
789
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
7.2
207
1408
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
7.2
446
3500
R4110, ,
SPAT
1.5
7.2
227
1576
S21
ICPC
Skin texture symptom/complaint
1.5
7.1
240
1687
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.1
606
4987
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
7.1
294
2151
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
7.1
358
2714
C09CA06
ATC
candesartan; oral
1.4
7.1
387
2973
R00.2
ICD-10 Finland
Palpitations
1.7
7.1
133
816
T78.4
ICD-10 Finland
Allergy, unspecified
2.0
7.1
72
365
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
7.0
91
500
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
7.0
71
359
H02BX01
ATC
methylprednisolone, combinations; systemic
2.0
7.0
76
394
SFA00
NOMESCO Finland
Small restoration
1.5
7.0
229
1600
M01AC06
ATC
meloxicam; systemic, rectal
1.3
7.0
589
4837
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.0
7.0
30
102
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
7.0
38
147
D07AD01
ATC
clobetasol; topical
1.5
6.9
270
1954
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
6.9
308
2284
R63.4
ICD-10 Finland
Abnormal weight loss
2.1
6.9
66
327
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.6
6.9
22
62
C07AB07
ATC
bisoprolol; oral
1.3
6.9
723
6121
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
6.9
117
699
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
6.9
146
925
F34.1
ICD-10 Finland
Dysthymia
2.2
6.8
58
274
H01
ICPC
Ear pain/earache
1.6
6.8
180
1200
A07AA02
ATC
nystatin; oral
1.9
6.8
85
462
T08
ICPC
Weight loss
2.9
6.8
31
109
A01AB04
ATC
amphotericin B; local oral
2.0
6.8
72
370
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
6.8
196
1333
L86
ICPC
Back syndrome with radiating pain
1.8
6.8
98
558
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.8
349
2653
XQ800
NOMESCO Finland
Prick test
1.7
6.7
116
695
A03
ICPC
Fever
1.5
6.7
253
1817
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
6.7
130
804
SFA30
NOMESCO Finland
Three-surface restoration
1.3
6.7
689
5812
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
6.6
187
1265
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.6
380
2938
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.9
6.6
74
388
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
6.6
280
2056
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
6.6
192
1309
M02AA10
ATC
ketoprofen; topical
1.5
6.6
244
1748
M01AG02
ATC
tolfenamic acid; oral, rectal
1.5
6.6
241
1723
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.3
6.5
463
3699
H29
ICPC
Ear symptom/complaint other
1.5
6.5
193
1319
I49.1
ICD-10 Finland
Atrial premature depolarization
2.0
6.5
64
320
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.2
6.5
52
240
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
6.5
92
521
F29
ICPC
Eye symptom/complaint other
1.6
6.5
170
1132
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
6.5
491
3963
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
6.5
174
1166
P01
ICPC
Feeling anxious/nervous/tense
1.6
6.5
160
1052
C08DA01
ATC
verapamil; systemic
2.0
6.4
63
315
A03FA02
ATC
cisapride; oral, rectal
1.7
6.4
106
628
C10AC01
ATC
colestyramine; oral
2.3
6.4
46
203
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.4
6.4
42
178
ZXA05
NOMESCO Finland
Left side
1.4
6.4
358
2757
N01
ICPC
Headache
1.6
6.4
158
1039
M01AX05
ATC
glucosamine; oral
1.4
6.3
296
2210
A05
ICPC
Feeling ill
1.9
6.3
81
444
R03BA05
ATC
fluticasone; inhalant
1.4
6.3
269
1975
R03DC01
ATC
zafirlukast; oral
2.9
6.3
28
97
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
6.3
196
1354
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.3
195
1346
N05CD07
ATC
temazepam; oral
1.6
6.3
150
977
N94.1
ICD-10 Finland
Dyspareunia
3.5
6.3
21
61
ZXA10
NOMESCO Finland
Bilateral
1.4
6.3
262
1917
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
6.3
172
1157
J33
ICD-10 Finland
Nasal polyp
3.9
6.3
18
47
KMAK, ,
NOMESCO Finland
1.3
6.3
783
6757
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.2
170
1142
L04AX01
ATC
azathioprine; systemic
2.0
6.2
61
306
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
6.2
86
485
N05
ICPC
Tingling fingers/feet/toes
3.3
6.1
22
67
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
6.1
101
598
F32
ICD-10 Finland
Depressive episode
1.9
6.1
77
420
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.2
6.1
48
220
R19.6
ICD-10 Finland
Halitosis
7.7
6.1
13
17
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.0
6.1
67
349
N28
ICPC
Limited function/disability (N)
3.0
6.1
25
83
SDA03
NOMESCO Finland
Periodontal treatment
1.3
6.1
656
5548
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
6.1
420
3340
AA1BG, ,
SPAT
2.5
6.0
36
146
DM1QA, ,
SPAT
1.9
6.0
67
351
M79.7
ICD-10 Finland
Fibromyalgia
2.1
6.0
56
275
A02BC01
ATC
omeprazole; systemic
1.3
6.0
391
3080
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
6.7e-01
1.9e+00
1.6e+00
4.8e+00
2.4e+00
1.4e+00
8.0e-01
cases:16.54%
controls:9.21%
cases:20.82%
controls:3.81%
cases:3.07%
controls:0.64%
cases:4.51%
controls:0.04%
cases:6.13%
controls:0.58%
cases:13.55%
controls:3.82%
cases:18.58%
controls:9.33%
286
1593
1443
15697
360
658
1369
16632
53
111
1676
17179
78
7
1651
17283
106
100
1623
17162
229
643
1461
16190
279
1384
1223
13447
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
6.7e-01
1.9e+00
1.6e+00
4.8e+00
2.4e+00
1.4e+00
8.0e-01
cases:16.54%
controls:9.21%
cases:20.82%
controls:3.81%
cases:3.07%
controls:0.64%
cases:4.51%
controls:0.04%
cases:6.13%
controls:0.58%
cases:13.55%
controls:3.82%
cases:18.58%
controls:9.33%
286
1593
1443
15697
360
658
1369
16632
53
111
1676
17179
78
7
1651
17283
106
100
1623
17162
229
643
1461
16190
279
1384
1223
13447
Otolaryngology
4 [38004449]
4 [38004449]
7.8e-01
1.1e+00
1.7e+00
—
3.4e+00
3.1e+00
9.7e-01
cases:18.05%
controls:9.16%
cases:9.60%
controls:3.36%
cases:2.66%
controls:0.48%
—
—
cases:13.53%
controls:0.53%
cases:41.95%
controls:3.23%
cases:22.30%
controls:9.82%
312
1583
1417
15707
166
581
1563
16709
46
83
1683
17207
—
234
92
1495
17170
709
543
981
16290
335
1457
1167
13374
Outpatient Visit
OP [9202]
OP [9202]
5.0e-01
5.1e-01
5.4e-01
6.3e+00
1.1e+00
1.2e+00
7.3e-01
cases:77.91%
controls:68.06%
cases:59.17%
controls:46.62%
cases:15.21%
controls:9.49%
cases:68.71%
controls:0.41%
cases:23.89%
controls:9.32%
cases:73.02%
controls:45.97%
cases:87.75%
controls:77.47%
1347
11768
382
5522
1023
8061
706
9229
263
1641
1466
15649
1188
71
541
17219
413
1609
1316
15653
1234
7738
456
9095
1318
11490
184
3341
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
1.9e+00
2.2e+00
3.0e+00
1.0e+50
—
1.8e+00
1.7e+00
cases:4.51%
controls:0.71%
cases:2.43%
controls:0.27%
cases:0.69%
controls:0.03%
cases:0.46%
controls:0.00%
—
—
cases:2.01%
controls:0.33%
cases:6.79%
controls:1.30%
78
122
1651
17168
42
46
1687
17244
12
6
1717
17284
8
0
1721
17290
—
34
55
1656
16778
102
193
1400
14638
Chronic maxillary sinusitis
J32.0 [45586667]
J32.0 [45586667]
1.2e+00
1.9e+00
2.0e+00
1.0e+50
2.6e+00
2.6e+00
1.4e+00
cases:2.37%
controls:0.74%
cases:1.50%
controls:0.22%
cases:0.29%
controls:0.04%
cases:0.98%
controls:0.00%
cases:0.52%
controls:0.04%
cases:2.66%
controls:0.20%
cases:2.80%
controls:0.67%
41
128
1688
17162
26
38
1703
17252
5
7
1724
17283
17
0
1712
17290
9
7
1720
17255
45
34
1645
16799
42
100
1460
14731
Chronic rhinitis
J31.0 [45572165]
J31.0 [45572165]
1.1e+00
2.3e+00
1.9e+00
1.0e+50
2.7e+00
2.1e+00
1.3e+00
cases:1.79%
controls:0.60%
cases:2.66%
controls:0.26%
cases:0.35%
controls:0.05%
cases:1.79%
controls:0.00%
cases:0.52%
controls:0.03%
cases:2.01%
controls:0.24%
cases:3.00%
controls:0.87%
31
103
1698
17187
46
45
1683
17245
6
9
1723
17281
31
0
1698
17290
9
6
1720
17256
34
41
1656
16792
45
129
1457
14702
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
DMB20 [2001301780]
1.3e+00
2.1e+00
—
—
—
3.6e+00
1.9e+00
cases:1.10%
controls:0.31%
cases:0.64%
controls:0.08%
—
—
—
—
—
—
cases:1.83%
controls:0.05%
cases:1.53%
controls:0.24%
19
54
1710
17236
11
13
1718
17277
—
—
—
31
9
1659
16824
23
36
1479
14795
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
6.6e-01
7.6e-01
5.6e-01
3.9e+00
1.3e+00
8.8e-01
7.4e-01
cases:11.28%
controls:6.16%
cases:5.15%
controls:2.48%
cases:0.81%
controls:0.46%
cases:1.62%
controls:0.03%
cases:1.39%
controls:0.36%
cases:5.74%
controls:2.45%
cases:13.25%
controls:6.78%
195
1065
1534
16225
89
429
1640
16861
14
80
1715
17210
28
6
1701
17284
24
63
1705
17199
97
413
1593
16420
199
1005
1303
13826
Neurology
13 [38004458]
13 [38004458]
7.0e-01
1.1e+00
1.5e+00
—
2.0e+00
1.8e+00
1.0e+00
cases:13.59%
controls:7.26%
cases:8.56%
controls:3.09%
cases:2.49%
controls:0.57%
—
—
cases:3.99%
controls:0.56%
cases:15.27%
controls:3.02%
cases:18.18%
controls:7.57%
235
1255
1494
16035
148
534
1581
16756
43
98
1686
17192
—
69
97
1660
17165
258
508
1432
16325
273
1122
1229
13709
Other polyp of sinus
J33.8 [45591556]
J33.8 [45591556]
1.4e+00
1.9e+00
—
1.0e+50
2.3e+00
2.8e+00
1.8e+00
cases:0.64%
controls:0.15%
cases:0.69%
controls:0.10%
—
—
cases:0.29%
controls:0.00%
cases:0.29%
controls:0.03%
cases:0.95%
controls:0.06%
cases:0.87%
controls:0.14%
11
26
1718
17264
12
18
1717
17272
—
5
0
1724
17290
5
5
1724
17257
16
10
1674
16823
13
21
1489
14810
CT of paranasal sinuses and face area
DM1AD [2001301741]
DM1AD [2001301741]
8.1e-01
3.2e+00
—
1.0e+50
—
3.3e+00
1.3e+00
cases:0.64%
controls:0.28%
cases:0.69%
controls:0.03%
—
—
cases:2.14%
controls:0.00%
—
—
cases:1.24%
controls:0.05%
cases:0.73%
controls:0.20%
11
49
1718
17241
12
5
1717
17285
—
37
0
1692
17290
—
21
8
1669
16825
11
29
1491
14802
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
5.6e-01
1.7e+00
1.2e+00
—
2.4e+00
1.2e+00
6.2e-01
cases:15.96%
controls:9.76%
cases:17.93%
controls:3.93%
cases:1.91%
controls:0.57%
—
—
cases:6.07%
controls:0.56%
cases:11.30%
controls:3.67%
cases:15.85%
controls:9.17%
276
1687
1453
15603
310
680
1419
16610
33
99
1696
17191
—
105
96
1624
17166
191
617
1499
16216
238
1360
1264
13471
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
2.7e+00
—
—
1.0e+50
—
2.9e+00
2.1e+00
cases:1.21%
controls:0.09%
—
—
—
—
cases:0.29%
controls:0.00%
—
—
cases:1.36%
controls:0.08%
cases:2.40%
controls:0.29%
21
15
1708
17275
—
—
5
0
1724
17290
—
23
13
1667
16820
36
43
1466
14788
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
8.9e-01
1.3e+00
3.6e-01
2.0e+00
5.1e-01
9.4e-01
1.4e+00
cases:97.92%
controls:95.06%
cases:95.49%
controls:85.59%
cases:54.48%
controls:45.59%
cases:15.73%
controls:2.41%
cases:57.55%
controls:44.82%
cases:94.08%
controls:86.18%
cases:99.00%
controls:96.10%
1693
16436
36
854
1651
14799
78
2491
942
7883
787
9407
272
417
1457
16873
995
7736
734
9526
1590
14506
100
2327
1487
14252
15
579
Malaise and fatigue
R53 [45553741]
R53 [45553741]
7.6e-01
1.3e+00
1.6e+00
1.0e+50
1.9e+00
8.0e-01
7.9e-01
cases:3.99%
controls:1.91%
cases:2.37%
controls:0.68%
cases:0.46%
controls:0.09%
cases:0.29%
controls:0.00%
cases:0.40%
controls:0.06%
cases:1.95%
controls:0.89%
cases:7.06%
controls:3.32%
69
330
1660
16960
41
117
1688
17173
8
16
1721
17274
5
0
1724
17290
7
11
1722
17251
33
149
1657
16684
106
492
1396
14339
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.8e-01
-6.3e-01
-7.2e-03
—
2.3e+00
2.8e+00
3.0e+00
cases:15.04%
controls:25.86%
cases:5.03%
controls:9.02%
cases:0.81%
controls:0.82%
—
—
cases:0.52%
controls:0.05%
cases:6.98%
controls:0.45%
cases:17.78%
controls:1.02%
260
4472
1469
12818
87
1559
1642
15731
14
141
1715
17149
—
9
9
1720
17253
118
75
1572
16758
267
151
1235
14680
Rhinopharyngoscopy
UDH02 [2001301680]
UDH02 [2001301680]
8.4e-01
2.1e+00
—
1.0e+50
—
2.6e+00
1.2e+00
cases:1.27%
controls:0.56%
cases:1.04%
controls:0.13%
—
—
cases:9.14%
controls:0.00%
—
—
cases:2.13%
controls:0.16%
cases:1.73%
controls:0.51%
22
96
1707
17194
18
23
1711
17267
—
158
0
1571
17290
—
36
27
1654
16806
26
75
1476
14756
Neurosurgery
14 [38004459]
14 [38004459]
7.7e-01
1.3e+00
1.7e+00
—
9.6e-01
1.6e+00
1.1e+00
cases:4.45%
controls:2.12%
cases:3.07%
controls:0.82%
cases:0.58%
controls:0.10%
—
—
cases:0.35%
controls:0.13%
cases:3.02%
controls:0.65%
cases:6.26%
controls:2.08%
77
366
1652
16924
53
141
1676
17149
10
18
1719
17272
—
6
23
1723
17239
51
109
1639
16724
94
308
1408
14523
triamcinolone; nasal
R01AD11 [21605052]
R01AD11 [21605052]
7.7e-01
1.7e+00
—
1.0e+50
2.7e+00
1.3e+00
8.3e-01
cases:1.39%
controls:0.65%
cases:1.50%
controls:0.29%
—
—
cases:0.35%
controls:0.00%
cases:0.52%
controls:0.03%
cases:0.95%
controls:0.26%
cases:1.26%
controls:0.55%
24
112
1705
17178
26
50
1703
17240
—
6
0
1723
17290
9
6
1720
17256
16
43
1674
16790
19
82
1483
14749
Deviated nasal septum
J34.2 [45562448]
J34.2 [45562448]
5.3e-01
1.9e+00
—
1.0e+50
—
2.8e+00
1.5e+00
cases:0.46%
controls:0.27%
cases:0.46%
controls:0.07%
—
—
cases:0.93%
controls:0.00%
—
—
cases:1.18%
controls:0.07%
cases:1.07%
controls:0.25%
8
47
1721
17243
8
12
1721
17278
—
16
0
1713
17290
—
20
12
1670
16821
16
37
1486
14794
azelastine; nasal
R01AC03 [21605035]
R01AC03 [21605035]
6.4e-01
1.2e+00
1.1e+00
—
1.8e+00
8.9e-01
5.4e-01
cases:6.71%
controls:3.65%
cases:7.06%
controls:2.18%
cases:0.81%
controls:0.28%
—
—
cases:1.68%
controls:0.28%
cases:5.09%
controls:2.14%
cases:8.72%
controls:5.27%
116
631
1613
16659
122
377
1607
16913
14
48
1715
17242
—
29
49
1700
17213
86
361
1604
16472
131
782
1371
14049
fluticasone, combinations
R01AD58 [43534837]
R01AD58 [43534837]
6.5e-01
1.2e+00
1.1e+00
—
1.8e+00
8.9e-01
5.3e-01
cases:6.71%
controls:3.63%
cases:7.06%
controls:2.16%
cases:0.81%
controls:0.28%
—
—
cases:1.68%
controls:0.28%
cases:5.03%
controls:2.14%
cases:8.59%
controls:5.24%
116
627
1613
16663
122
374
1607
16916
14
48
1715
17242
—
29
49
1700
17213
85
360
1605
16473
129
777
1373
14054
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.9e-01
4.2e-01
3.2e-01
3.7e+00
1.1e+00
7.6e-01
5.0e-01
cases:8.91%
controls:7.50%
cases:3.41%
controls:2.28%
cases:0.40%
controls:0.29%
cases:1.21%
controls:0.03%
cases:0.87%
controls:0.28%
cases:4.26%
controls:2.04%
cases:9.39%
controls:5.89%
154
1297
1575
15993
59
394
1670
16896
7
51
1722
17239
21
5
1708
17285
15
49
1714
17213
72
343
1618
16490
141
874
1361
13957
Cone beam CT of paranasal sinus
DM1AI [2001301744]
DM1AI [2001301744]
6.9e-01
2.7e+00
—
1.0e+50
—
3.3e+00
9.1e-01
cases:0.35%
controls:0.17%
cases:0.58%
controls:0.04%
—
—
cases:3.01%
controls:0.00%
—
—
cases:1.24%
controls:0.05%
cases:0.47%
controls:0.19%
6
30
1723
17260
10
7
1719
17283
—
52
0
1677
17290
—
21
8
1669
16825
7
28
1495
14803
Puncture of maxillary antrum
TDM10 [2001301819]
TDM10 [2001301819]
1.3e+00
2.1e+00
—
1.0e+50
—
2.4e+00
2.6e-01
cases:0.93%
controls:0.25%
cases:0.40%
controls:0.05%
—
—
cases:0.58%
controls:0.00%
—
—
cases:0.77%
controls:0.07%
cases:0.33%
controls:0.26%
16
44
1713
17246
7
9
1722
17281
—
10
0
1719
17290
—
13
12
1677
16821
5
38
1497
14793
Internal Medicine
11 [38004456]
11 [38004456]
3.9e-01
4.6e-01
8.2e-01
3.0e+00
5.8e-01
5.0e-01
5.4e-01
cases:25.33%
controls:18.66%
cases:10.70%
controls:7.06%
cases:2.54%
controls:1.14%
cases:1.16%
controls:0.06%
cases:2.08%
controls:1.18%
cases:10.77%
controls:6.79%
cases:25.83%
controls:16.83%
438
3226
1291
14064
185
1220
1544
16070
44
197
1685
17093
20
10
1709
17280
36
203
1693
17059
182
1143
1508
15690
388
2496
1114
12335
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
7.8e-01
1.3e+00
—
1.0e+50
—
2.8e+00
1.6e+00
cases:1.27%
controls:0.59%
cases:0.93%
controls:0.25%
—
—
cases:2.60%
controls:0.00%
—
—
cases:2.72%
controls:0.17%
cases:2.73%
controls:0.58%
22
102
1707
17188
16
44
1713
17246
—
45
0
1684
17290
—
46
29
1644
16804
41
86
1461
14745
Traumatic subdural haemorrhage
S06.5 [45563422]
S06.5 [45563422]
1.0e+00
3.2e+00
—
—
—
2.5e+00
3.4e-01
cases:0.29%
controls:0.10%
cases:0.81%
controls:0.03%
—
—
—
—
—
—
cases:0.41%
controls:0.04%
cases:0.33%
controls:0.24%
5
18
1724
17272
14
6
1715
17284
—
—
—
7
6
1683
16827
5
35
1497
14796
Focal brain injury
S06.3 [45606905]
S06.3 [45606905]
—
3.2e+00
1.0e+50
1.0e+50
—
1.0e+50
2.2e+00
—
—
cases:0.69%
controls:0.03%
cases:0.29%
controls:0.00%
cases:0.40%
controls:0.00%
—
—
cases:0.53%
controls:0.00%
cases:0.47%
controls:0.05%
—
12
5
1717
17285
5
0
1724
17290
7
0
1722
17290
—
9
0
1681
16833
7
8
1495
14823
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
4.9e-01
1.6e+00
—
1.0e+50
—
2.8e+00
9.6e-01
cases:1.10%
controls:0.68%
cases:0.87%
controls:0.19%
—
—
cases:2.83%
controls:0.00%
—
—
cases:2.72%
controls:0.18%
cases:1.86%
controls:0.72%
19
117
1710
17173
15
32
1714
17258
—
49
0
1680
17290
—
46
30
1644
16803
28
107
1474
14724
Polyp of nasal cavity
J33.0 [45562447]
J33.0 [45562447]
6.2e-01
2.4e+00
—
1.0e+50
—
2.8e+00
1.1e+00
cases:0.46%
controls:0.25%
cases:0.93%
controls:0.09%
—
—
cases:1.16%
controls:0.00%
—
—
cases:1.36%
controls:0.08%
cases:0.80%
controls:0.26%
8
43
1721
17247
16
15
1713
17275
—
20
0
1709
17290
—
23
14
1667
16819
12
39
1490
14792
Inpatient Hospital
21 [8717]
21 [8717]
2.6e-01
4.1e-01
5.5e-01
3.6e+00
3.5e-01
4.8e-01
3.6e-01
cases:33.20%
controls:27.79%
cases:12.26%
controls:8.52%
cases:1.97%
controls:1.15%
cases:1.27%
controls:0.03%
cases:1.50%
controls:1.06%
cases:12.01%
controls:7.76%
cases:26.36%
controls:20.06%
574
4805
1155
12485
212
1473
1517
15817
34
198
1695
17092
22
6
1707
17284
26
183
1703
17079
203
1306
1487
15527
396
2975
1106
11856
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
2.8e-01
4.6e-01
6.9e-01
2.3e+00
5.9e-01
3.2e-01
3.7e-01
cases:27.07%
controls:21.93%
cases:13.94%
controls:9.26%
cases:2.95%
controls:1.50%
cases:0.40%
controls:0.04%
cases:2.89%
controls:1.63%
cases:12.19%
controls:9.15%
cases:29.03%
controls:21.95%
468
3792
1261
13498
241
1601
1488
15689
51
259
1678
17031
7
7
1722
17283
50
281
1679
16981
206
1540
1484
15293
436
3256
1066
11575
Sequelae of intracranial injury
T90.5 [45537098]
T90.5 [45537098]
—
2.0e+00
—
—
—
2.4e+00
2.6e+00
—
—
cases:0.29%
controls:0.04%
—
—
—
—
—
—
cases:0.53%
controls:0.05%
cases:1.07%
controls:0.08%
—
5
7
1724
17283
—
—
—
9
8
1681
16825
16
12
1486
14819
Headache
R51.80 [2000503603]
R51.80 [2000503603]
7.2e-01
1.2e+00
2.1e+00
1.0e+50
—
9.3e-01
1.1e+00
cases:3.01%
controls:1.49%
cases:1.33%
controls:0.42%
cases:0.40%
controls:0.05%
cases:0.40%
controls:0.00%
—
—
cases:0.95%
controls:0.37%
cases:3.99%
controls:1.40%
52
258
1677
17032
23
73
1706
17217
7
9
1722
17281
7
0
1722
17290
—
16
63
1674
16770
60
208
1442
14623
Hypersensitivity skin testing
268377001 [4147813]
268377001 [4147813]
5.4e-01
1.6e+00
—
1.0e+50
2.5e+00
9.9e-01
9.5e-01
cases:1.56%
controls:0.91%
cases:0.93%
controls:0.20%
—
—
cases:0.52%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.65%
controls:0.24%
cases:1.73%
controls:0.67%
27
158
1702
17132
16
34
1713
17256
—
9
0
1720
17290
6
5
1723
17257
11
41
1679
16792
26
100
1476
14731
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
3.3e-01
1.0e+00
1.1e+00
—
1.3e+00
7.0e-01
5.6e-01
cases:7.23%
controls:5.30%
cases:7.23%
controls:2.75%
cases:0.87%
controls:0.28%
—
—
cases:0.87%
controls:0.25%
cases:5.80%
controls:2.97%
cases:16.78%
controls:10.34%
125
917
1604
16373
125
475
1604
16815
15
49
1714
17241
—
15
43
1714
17219
98
500
1592
16333
252
1533
1250
13298
Audiology
64 [38004489]
64 [38004489]
6.2e-01
7.8e-01
1.2e+00
—
1.7e+00
1.1e+00
7.9e-01
cases:3.70%
controls:2.02%
cases:1.91%
controls:0.88%
cases:0.46%
controls:0.13%
—
—
cases:0.69%
controls:0.13%
cases:2.78%
controls:0.93%
cases:5.59%
controls:2.62%
64
350
1665
16940
33
153
1696
17137
8
23
1721
17267
—
12
23
1717
17239
47
157
1643
16676
84
388
1418
14443
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
14685-2 [3009035]
3.0e-01
9.0e-01
1.8e+00
—
1.5e+00
7.4e-01
1.5e-01
cases:4.16%
controls:3.12%
cases:3.12%
controls:1.29%
cases:0.58%
controls:0.10%
—
—
cases:0.52%
controls:0.12%
cases:2.49%
controls:1.20%
cases:5.73%
controls:4.96%
72
540
1657
16750
54
223
1675
17067
10
17
1719
17273
—
9
20
1720
17242
42
202
1648
16631
86
735
1416
14096
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
-1.1e-02
1.0e+00
—
—
2.3e+00
7.3e-01
8.4e-01
cases:2.66%
controls:2.69%
cases:2.49%
controls:0.90%
—
—
—
—
cases:0.35%
controls:0.03%
cases:1.66%
controls:0.81%
cases:5.59%
controls:2.50%
46
465
1683
16825
43
155
1686
17135
—
—
6
6
1723
17256
28
136
1662
16697
84
371
1418
14460
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.5e-01
2.8e-01
4.8e-01
3.4e+00
4.4e-01
2.5e-01
1.3e-01
cases:63.33%
controls:59.83%
cases:58.88%
controls:51.94%
cases:29.21%
controls:20.31%
cases:28.05%
controls:1.28%
cases:28.17%
controls:20.11%
cases:61.18%
controls:55.17%
cases:78.96%
controls:76.74%
1095
10345
634
6945
1018
8980
711
8310
505
3512
1224
13778
485
222
1244
17068
487
3472
1242
13790
1034
9286
656
7547
1186
11381
316
3450
Benign tumor of the meninges at the base of the brain
D32.02 [2000501309]
D32.02 [2000501309]
-1.0e+50
—
—
—
—
2.6e+00
2.2e+00
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:0.87%
controls:0.09%
0
11
1729
17279
—
—
—
—
11
8
1679
16825
13
14
1489
14817
Outpatient Hospital
22 [8756]
22 [8756]
2.6e-01
4.8e-01
3.0e-01
3.0e+00
4.1e-01
6.5e-01
4.4e-01
cases:27.76%
controls:22.87%
cases:9.66%
controls:6.18%
cases:1.21%
controls:0.90%
cases:0.69%
controls:0.03%
cases:1.16%
controls:0.77%
cases:10.41%
controls:5.72%
cases:22.77%
controls:15.97%
480
3955
1249
13335
167
1068
1562
16222
21
156
1708
17134
12
6
1717
17284
20
133
1709
17129
176
963
1514
15870
342
2368
1160
12463
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.9e-01
9.9e-01
9.4e-01
—
1.1e+00
6.9e-01
5.3e-01
cases:15.15%
controls:9.87%
cases:10.93%
controls:4.37%
cases:1.79%
controls:0.71%
—
—
cases:2.31%
controls:0.77%
cases:8.28%
controls:4.34%
cases:17.64%
controls:11.21%
262
1706
1467
15584
189
755
1540
16535
31
123
1698
17167
—
40
133
1689
17129
140
730
1550
16103
265
1662
1237
13169
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.9e-01
9.8e-01
9.4e-01
—
1.1e+00
6.9e-01
5.3e-01
cases:15.10%
controls:9.81%
cases:10.82%
controls:4.34%
cases:1.79%
controls:0.71%
—
—
cases:2.31%
controls:0.77%
cases:8.28%
controls:4.33%
cases:17.58%
controls:11.15%
261
1697
1468
15593
187
751
1542
16539
31
123
1698
17167
—
40
133
1689
17129
140
729
1550
16104
264
1653
1238
13178
Observation for suspected nervous system disorder
Z03.3 [45609903]
Z03.3 [45609903]
1.0e+00
1.2e+00
—
—
1.0e+50
2.4e+00
1.2e+00
cases:1.04%
controls:0.37%
cases:0.40%
controls:0.13%
—
—
—
—
cases:0.29%
controls:0.00%
cases:0.95%
controls:0.08%
cases:1.00%
controls:0.30%
18
64
1711
17226
7
22
1722
17268
—
—
5
0
1724
17262
16
14
1674
16819
15
44
1487
14787
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
2.9e-01
5.2e-01
7.3e-01
2.1e+00
2.7e-01
5.4e-01
5.1e-01
cases:9.43%
controls:7.20%
cases:9.08%
controls:5.60%
cases:2.14%
controls:1.05%
cases:0.40%
controls:0.05%
cases:1.56%
controls:1.19%
cases:9.35%
controls:5.64%
cases:18.38%
controls:11.87%
163
1245
1566
16045
157
968
1572
16322
37
181
1692
17109
7
9
1722
17281
27
206
1702
17056
158
950
1532
15883
276
1760
1226
13071
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
5.8e-01
6.5e-01
—
—
1.6e+00
9.3e-01
8.2e-01
cases:5.67%
controls:3.24%
cases:2.89%
controls:1.53%
—
—
—
—
cases:0.75%
controls:0.15%
cases:3.73%
controls:1.50%
cases:9.99%
controls:4.64%
98
561
1631
16729
50
264
1679
17026
—
—
13
26
1716
17236
63
253
1627
16580
150
688
1352
14143
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
8.2e-01
1.4e+00
—
—
1.6e+00
1.3e+00
1.0e+00
cases:1.62%
controls:0.72%
cases:0.87%
controls:0.21%
—
—
—
—
cases:0.35%
controls:0.07%
cases:1.07%
controls:0.29%
cases:2.26%
controls:0.83%
28
125
1701
17165
15
36
1714
17254
—
—
6
12
1723
17250
18
48
1672
16785
34
123
1468
14708
Psychiatry
26 [38004469]
26 [38004469]
2.2e-01
4.1e-01
5.9e-01
2.1e+00
8.9e-01
6.7e-01
7.7e-01
cases:6.30%
controls:5.14%
cases:3.64%
controls:2.45%
cases:1.79%
controls:1.01%
cases:0.58%
controls:0.07%
cases:2.14%
controls:0.89%
cases:4.56%
controls:2.38%
cases:9.32%
controls:4.54%
109
889
1620
16401
63
424
1666
16866
31
174
1698
17116
10
12
1719
17278
37
153
1692
17109
77
400
1613
16433
140
674
1362
14157
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
3.0e-01
2.2e+00
—
1.0e+50
—
2.3e+00
8.3e-01
cases:0.29%
controls:0.21%
cases:0.35%
controls:0.04%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.59%
controls:0.06%
cases:0.40%
controls:0.18%
5
37
1724
17253
6
7
1723
17283
—
5
0
1724
17290
—
10
10
1680
16823
6
26
1496
14805
Cardiac arrhythmia NOS
K80 [2002000607]
K80 [2002000607]
8.3e-01
1.3e+00
—
—
—
1.4e+00
8.7e-01
cases:1.56%
controls:0.69%
cases:0.87%
controls:0.23%
—
—
—
—
—
—
cases:0.83%
controls:0.21%
cases:2.13%
controls:0.90%
27
119
1702
17171
15
40
1714
17250
—
—
—
14
35
1676
16798
32
134
1470
14697
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
G03BA03 [21602510]
1.1e+00
1.2e+00
8.4e-01
—
8.2e-01
1.2e+00
9.5e-01
cases:1.74%
controls:0.58%
cases:1.21%
controls:0.39%
cases:0.35%
controls:0.15%
—
—
cases:0.29%
controls:0.13%
cases:1.30%
controls:0.41%
cases:1.26%
controls:0.49%
30
100
1699
17190
21
67
1708
17223
6
26
1723
17264
—
5
22
1724
17240
22
69
1668
16764
19
73
1483
14758
Concussion
S06.0 [45582805]
S06.0 [45582805]
6.0e-01
1.9e+00
2.5e+00
1.0e+50
—
9.4e-01
2.6e-01
cases:1.50%
controls:0.83%
cases:1.33%
controls:0.21%
cases:0.35%
controls:0.03%
cases:0.35%
controls:0.00%
—
—
cases:0.53%
controls:0.21%
cases:1.26%
controls:0.98%
26
144
1703
17146
23
36
1706
17254
6
5
1723
17285
6
0
1723
17290
—
9
35
1681
16798
19
145
1483
14686
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7818-8 [3008230]
2.4e-01
2.1e-01
—
—
2.2e+00
1.3e+00
8.1e-01
cases:1.39%
controls:1.09%
cases:0.46%
controls:0.38%
—
—
—
—
cases:0.40%
controls:0.05%
cases:1.12%
controls:0.30%
cases:2.93%
controls:1.32%
24
189
1705
17101
8
65
1721
17225
—
—
7
8
1722
17254
19
50
1671
16783
44
196
1458
14635
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
6.6e-01
9.7e-01
—
—
—
1.4e+00
1.2e+00
cases:3.01%
controls:1.58%
cases:1.27%
controls:0.49%
—
—
—
—
—
—
cases:1.42%
controls:0.34%
cases:3.13%
controls:0.92%
52
273
1677
17017
22
84
1707
17206
—
—
—
24
57
1666
16776
47
137
1455
14694
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
6.6e-01
9.7e-01
—
—
—
1.4e+00
1.2e+00
cases:3.01%
controls:1.58%
cases:1.27%
controls:0.49%
—
—
—
—
—
—
cases:1.42%
controls:0.34%
cases:3.13%
controls:0.92%
52
273
1677
17017
22
84
1707
17206
—
—
—
24
57
1666
16776
47
137
1455
14694
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
6.6e-01
9.7e-01
—
—
—
1.4e+00
1.2e+00
cases:3.01%
controls:1.58%
cases:1.27%
controls:0.49%
—
—
—
—
—
—
cases:1.42%
controls:0.34%
cases:3.13%
controls:0.92%
52
273
1677
17017
22
84
1707
17206
—
—
—
24
57
1666
16776
47
137
1455
14694
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
6.6e-01
9.7e-01
—
—
—
1.4e+00
1.2e+00
cases:3.01%
controls:1.58%
cases:1.27%
controls:0.49%
—
—
—
—
—
—
cases:1.42%
controls:0.34%
cases:3.13%
controls:0.92%
52
273
1677
17017
22
84
1707
17206
—
—
—
24
57
1666
16776
47
137
1455
14694
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
6.6e-01
9.7e-01
—
—
—
1.4e+00
1.2e+00
cases:3.01%
controls:1.58%
cases:1.27%
controls:0.49%
—
—
—
—
—
—
cases:1.42%
controls:0.34%
cases:3.13%
controls:0.92%
52
273
1677
17017
22
84
1707
17206
—
—
—
24
57
1666
16776
47
137
1455
14694
betahistine; oral
N07CA01 [21604833]
N07CA01 [21604833]
9.4e-01
1.3e+00
1.3e+00
—
1.1e+00
1.0e+00
1.1e+00
cases:1.62%
controls:0.64%
cases:1.16%
controls:0.33%
cases:0.35%
controls:0.09%
—
—
cases:0.29%
controls:0.09%
cases:0.95%
controls:0.35%
cases:1.73%
controls:0.59%
28
110
1701
17180
20
57
1709
17233
6
16
1723
17274
—
5
16
1724
17246
16
59
1674
16774
26
88
1476
14743
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.6e-01
5.7e-01
7.1e-01
1.9e+00
2.8e-01
3.7e-01
4.1e-01
cases:29.21%
controls:24.18%
cases:24.64%
controls:15.54%
cases:5.61%
controls:2.84%
cases:0.87%
controls:0.13%
cases:3.76%
controls:2.88%
cases:21.12%
controls:15.56%
cases:46.40%
controls:36.46%
505
4180
1224
13110
426
2687
1303
14603
97
491
1632
16799
15
23
1714
17267
65
497
1664
16765
357
2619
1333
14214
697
5407
805
9424
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
D32.00 [2000501307]
—
—
—
—
—
2.7e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:0.60%
controls:0.13%
—
—
—
—
—
10
7
1680
16826
9
19
1493
14812
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
6.0e-01
8.4e-01
—
—
—
1.3e+00
1.3e+00
cases:3.30%
controls:1.84%
cases:1.33%
controls:0.58%
—
—
—
—
—
—
cases:1.66%
controls:0.45%
cases:3.73%
controls:1.02%
57
319
1672
16971
23
100
1706
17190
—
—
—
28
75
1662
16758
56
151
1446
14680
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
6.0e-01
8.4e-01
—
—
—
1.3e+00
1.3e+00
cases:3.30%
controls:1.84%
cases:1.33%
controls:0.58%
—
—
—
—
—
—
cases:1.66%
controls:0.45%
cases:3.73%
controls:1.02%
57
319
1672
16971
23
100
1706
17190
—
—
—
28
75
1662
16758
56
151
1446
14680
FEV1
20150-9 [3024653]
20150-9 [3024653]
6.0e-01
8.4e-01
—
—
—
1.3e+00
1.3e+00
cases:3.30%
controls:1.84%
cases:1.33%
controls:0.58%
—
—
—
—
—
—
cases:1.66%
controls:0.45%
cases:3.73%
controls:1.02%
57
319
1672
16971
23
100
1706
17190
—
—
—
28
75
1662
16758
56
151
1446
14680
Functional dysphonia
R49.01 [2000503597]
R49.01 [2000503597]
7.5e-01
—
—
—
—
2.1e+00
1.9e+00
cases:0.46%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:1.07%
controls:0.17%
8
38
1721
17252
—
—
—
—
6
7
1684
16826
16
25
1486
14806
Other and unspecified disturbances of smell and taste
R43.8 [45553738]
R43.8 [45553738]
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
4.0e+00
—
—
—
—
cases:1.56%
controls:0.00%
cases:28.17%
controls:0.00%
cases:3.76%
controls:0.00%
cases:11.30%
controls:0.00%
cases:1.80%
controls:0.03%
—
—
27
0
1702
17290
487
0
1242
17290
65
0
1664
17262
191
0
1499
16833
27
5
1475
14826
Migraine without aura [common migraine]
G43.0 [45600784]
G43.0 [45600784]
1.0e+00
1.0e+00
—
—
—
1.9e+00
1.0e+00
cases:1.45%
controls:0.53%
cases:0.64%
controls:0.23%
—
—
—
—
—
—
cases:0.95%
controls:0.14%
cases:1.80%
controls:0.65%
25
91
1704
17199
11
39
1718
17251
—
—
—
16
23
1674
16810
27
97
1475
14734
Fibromyalgia
M79.7 [45553272]
M79.7 [45553272]
8.0e-01
1.6e+00
—
—
—
1.4e+00
9.5e-01
cases:0.69%
controls:0.31%
cases:0.81%
controls:0.17%
—
—
—
—
—
—
cases:0.65%
controls:0.15%
cases:1.20%
controls:0.47%
12
54
1717
17236
14
29
1715
17261
—
—
—
11
26
1679
16807
18
69
1484
14762
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
6.4e-01
6.9e-01
7.6e-01
—
6.9e-01
5.6e-01
5.9e-01
cases:15.73%
controls:8.95%
cases:8.73%
controls:4.57%
cases:2.08%
controls:0.98%
—
—
cases:1.74%
controls:0.87%
cases:8.17%
controls:4.82%
cases:15.71%
controls:9.37%
272
1547
1457
15743
151
791
1578
16499
36
170
1693
17120
—
30
151
1699
17111
138
811
1552
16022
236
1389
1266
13442
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
6.5e-01
1.3e+00
—
—
2.0e+00
1.3e+00
6.7e-01
cases:2.14%
controls:1.13%
cases:1.16%
controls:0.32%
—
—
—
—
cases:0.29%
controls:0.04%
cases:1.12%
controls:0.31%
cases:2.46%
controls:1.27%
37
196
1692
17094
20
55
1709
17235
—
—
5
7
1724
17255
19
53
1671
16780
37
189
1465
14642
Seronegative rheumatoid arthritis
M06.0 [45577103]
M06.0 [45577103]
6.3e-01
1.2e+00
—
—
—
1.5e+00
1.2e+00
cases:0.69%
controls:0.37%
cases:0.75%
controls:0.23%
—
—
—
—
—
—
cases:0.89%
controls:0.20%
cases:1.13%
controls:0.36%
12
64
1717
17226
13
39
1716
17251
—
—
—
15
34
1675
16799
17
53
1485
14778
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
-1.7e-01
1.3e+00
—
1.0e+50
—
1.6e+00
9.4e-01
cases:0.40%
controls:0.48%
cases:0.64%
controls:0.17%
—
—
cases:2.95%
controls:0.00%
—
—
cases:0.83%
controls:0.17%
cases:1.26%
controls:0.50%
7
83
1722
17207
11
29
1718
17261
—
51
0
1678
17290
—
14
29
1676
16804
19
74
1483
14757
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
5.6e-01
7.1e-01
5.0e-01
—
1.0e+00
7.9e-01
7.1e-01
cases:10.35%
controls:6.17%
cases:4.63%
controls:2.32%
cases:0.64%
controls:0.39%
—
—
cases:1.27%
controls:0.46%
cases:4.67%
controls:2.17%
cases:13.12%
controls:6.90%
179
1067
1550
16223
80
401
1649
16889
11
67
1718
17223
—
22
80
1707
17182
79
366
1611
16467
197
1023
1305
13808
Other specified symptoms and signs involving the digestive system and abdomen
R19.8 [45558460]
R19.8 [45558460]
1.9e+00
—
—
—
—
—
1.9e+00
cases:0.46%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.08%
8
12
1721
17278
—
—
—
—
—
8
12
1494
14819
Emergency Room Visit
ER [9203]
ER [9203]
5.5e-01
6.4e-01
8.9e-01
—
6.3e-01
5.3e-01
5.5e-01
cases:41.41%
controls:28.91%
cases:16.25%
controls:9.32%
cases:2.54%
controls:1.06%
—
—
cases:2.02%
controls:1.08%
cases:14.02%
controls:8.77%
cases:36.95%
controls:25.32%
716
4999
1013
12291
281
1611
1448
15679
44
184
1685
17106
—
35
187
1694
17075
237
1476
1453
15357
555
3755
947
11076
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.0e-01
3.9e-01
3.5e-01
2.9e+00
1.2e-01
2.5e-01
4.7e-01
cases:8.62%
controls:6.55%
cases:5.61%
controls:3.89%
cases:1.68%
controls:1.19%
cases:0.52%
controls:0.03%
cases:1.27%
controls:1.14%
cases:4.79%
controls:3.79%
cases:15.58%
controls:10.32%
149
1132
1580
16158
97
672
1632
16618
29
206
1700
17084
9
5
1720
17285
22
196
1707
17066
81
638
1609
16195
234
1530
1268
13301
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
9.6e-02
2.7e-01
5.7e-01
2.2e+00
4.2e-01
2.6e-01
1.6e-01
cases:39.50%
controls:37.23%
cases:41.58%
controls:35.25%
cases:16.19%
controls:9.89%
cases:3.88%
controls:0.43%
cases:14.05%
controls:9.69%
cases:42.90%
controls:36.79%
cases:60.72%
controls:56.75%
683
6437
1046
10853
719
6094
1010
11196
280
1710
1449
15580
67
74
1662
17216
243
1673
1486
15589
725
6193
965
10640
912
8417
590
6414
Cerebral aneurysm, nonruptured
I67.1 [45538401]
I67.1 [45538401]
2.0e-01
1.2e+00
—
—
—
2.3e+00
1.4e+00
cases:0.29%
controls:0.24%
cases:0.35%
controls:0.10%
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:0.73%
controls:0.18%
5
41
1724
17249
6
18
1723
17272
—
—
—
12
12
1678
16821
11
26
1491
14805
tramadol and paracetamol
N02AJ13 [1123645]
N02AJ13 [1123645]
1.2e+00
—
—
—
—
1.7e+00
9.0e-01
cases:0.75%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.10%
cases:1.20%
controls:0.49%
13
41
1716
17249
—
—
—
—
9
17
1681
16816
18
73
1484
14758
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
7.9e-01
1.0e+00
—
—
—
1.1e+00
7.7e-01
cases:2.43%
controls:1.12%
cases:0.98%
controls:0.36%
—
—
—
—
—
—
cases:1.01%
controls:0.33%
cases:2.93%
controls:1.38%
42
193
1687
17097
17
62
1712
17228
—
—
—
17
55
1673
16778
44
204
1458
14627
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
4.2e-01
5.6e-01
1.4e-02
2.3e+00
5.0e-01
3.0e-01
4.2e-01
cases:8.62%
controls:5.84%
cases:5.90%
controls:3.46%
cases:0.87%
controls:0.86%
cases:0.35%
controls:0.03%
cases:1.27%
controls:0.78%
cases:4.67%
controls:3.49%
cases:8.26%
controls:5.57%
149
1010
1580
16280
102
598
1627
16692
15
148
1714
17142
6
6
1723
17284
22
134
1707
17128
79
588
1611
16245
124
826
1378
14005
Allergic rhinitis, unspecified
J30.4 [45548110]
J30.4 [45548110]
1.3e+00
2.4e+00
—
—
—
1.4e+00
9.6e-01
cases:0.75%
controls:0.21%
cases:0.75%
controls:0.07%
—
—
—
—
—
—
cases:0.36%
controls:0.09%
cases:0.93%
controls:0.36%
13
36
1716
17254
13
12
1716
17278
—
—
—
6
15
1684
16818
14
53
1488
14778
ciclesonide; inhalant
R03BA08 [21603291]
R03BA08 [21603291]
8.4e-01
8.3e-01
1.0e+00
—
3.6e-01
1.0e+00
9.6e-01
cases:2.95%
controls:1.30%
cases:2.02%
controls:0.90%
cases:0.75%
controls:0.27%
—
—
cases:0.29%
controls:0.20%
cases:2.43%
controls:0.90%
cases:4.59%
controls:1.81%
51
225
1678
17065
35
155
1694
17135
13
47
1716
17243
—
5
35
1724
17227
41
151
1649
16682
69
268
1433
14563
ciclesonide; nasal
R01AD13 [43534836]
R01AD13 [43534836]
8.4e-01
8.3e-01
1.0e+00
—
3.6e-01
1.0e+00
9.6e-01
cases:2.95%
controls:1.30%
cases:2.02%
controls:0.90%
cases:0.75%
controls:0.27%
—
—
cases:0.29%
controls:0.20%
cases:2.43%
controls:0.90%
cases:4.59%
controls:1.81%
51
225
1678
17065
35
155
1694
17135
13
47
1716
17243
—
5
35
1724
17227
41
151
1649
16682
69
268
1433
14563
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.6e-01
4.1e-01
6.9e-01
1.8e+00
2.7e-01
3.0e-01
3.5e-01
cases:29.50%
controls:26.22%
cases:27.30%
controls:19.94%
cases:6.77%
controls:3.52%
cases:0.81%
controls:0.13%
cases:4.11%
controls:3.15%
cases:26.15%
controls:20.70%
cases:51.26%
controls:42.65%
510
4534
1219
12756
472
3448
1257
13842
117
608
1612
16682
14
23
1715
17267
71
544
1658
16718
442
3485
1248
13348
770
6326
732
8505
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.2e-01
3.0e-01
6.6e-01
2.1e+00
1.3e-01
2.5e-01
2.1e-01
cases:30.13%
controls:27.57%
cases:24.00%
controls:19.01%
cases:5.73%
controls:3.03%
cases:0.93%
controls:0.11%
cases:3.59%
controls:3.16%
cases:23.08%
controls:18.97%
cases:46.21%
controls:40.93%
521
4767
1208
12523
415
3287
1314
14003
99
524
1630
16766
16
19
1713
17271
62
546
1667
16716
390
3193
1300
13640
694
6070
808
8761
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.5e-01
4.1e-01
6.9e-01
1.8e+00
2.9e-01
3.1e-01
3.4e-01
cases:29.55%
controls:26.44%
cases:27.59%
controls:20.21%
cases:6.88%
controls:3.59%
cases:0.81%
controls:0.13%
cases:4.28%
controls:3.25%
cases:26.51%
controls:20.97%
cases:51.46%
controls:42.96%
511
4572
1218
12718
477
3495
1252
13795
119
621
1610
16669
14
23
1715
17267
74
561
1655
16701
448
3530
1242
13303
773
6372
729
8459
Benign neoplasm: Pituitary gland
D35.2 [45581304]
D35.2 [45581304]
1.1e+00
1.6e+00
—
—
—
1.9e+00
1.6e+00
cases:0.35%
controls:0.12%
cases:0.29%
controls:0.06%
—
—
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.53%
controls:0.11%
6
20
1723
17270
5
10
1724
17280
—
—
—
7
10
1683
16823
8
16
1494
14815
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
3.4e-01
1.9e+00
—
—
—
1.6e+00
7.6e-01
cases:0.87%
controls:0.62%
cases:1.10%
controls:0.16%
—
—
—
—
—
—
cases:1.24%
controls:0.25%
cases:1.40%
controls:0.66%
15
107
1714
17183
19
28
1710
17262
—
—
—
21
42
1669
16791
21
98
1481
14733
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
4.1e-02
1.9e+00
—
—
—
1.8e+00
1.7e+00
cases:0.29%
controls:0.28%
cases:0.40%
controls:0.06%
—
—
—
—
—
—
cases:0.30%
controls:0.05%
cases:1.07%
controls:0.20%
5
48
1724
17242
7
11
1722
17279
—
—
—
5
8
1685
16825
16
30
1486
14801
Benign paroxysmal vertigo
H81.1 [45572061]
H81.1 [45572061]
7.0e-01
1.2e+00
—
1.0e+50
—
1.6e+00
6.6e-01
cases:1.39%
controls:0.69%
cases:0.98%
controls:0.29%
—
—
cases:0.46%
controls:0.00%
—
—
cases:0.95%
controls:0.19%
cases:2.40%
controls:1.25%
24
120
1705
17170
17
51
1712
17239
—
8
0
1721
17290
—
16
32
1674
16801
36
186
1466
14645
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.3e-01
3.8e-01
5.9e-01
1.6e+00
3.8e-01
3.1e-01
2.6e-01
cases:32.33%
controls:29.55%
cases:31.35%
controls:23.82%
cases:8.16%
controls:4.70%
cases:0.98%
controls:0.21%
cases:6.30%
controls:4.38%
cases:30.77%
controls:24.65%
cases:53.99%
controls:47.44%
559
5110
1170
12180
542
4118
1187
13172
141
813
1588
16477
17
36
1712
17254
109
756
1620
16506
520
4149
1170
12684
811
7036
691
7795
Pain in throat
R07.0 [45592406]
R07.0 [45592406]
1.1e+00
1.6e+00
—
—
—
8.3e-01
7.9e-01
cases:1.33%
controls:0.47%
cases:0.81%
controls:0.16%
—
—
—
—
—
—
cases:0.36%
controls:0.15%
cases:1.86%
controls:0.86%
23
81
1706
17209
14
28
1715
17262
—
—
—
6
26
1684
16807
28
127
1474
14704
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
1.7e-01
2.0e-01
5.3e-01
3.2e+00
3.0e-01
2.6e-01
2.1e-01
cases:16.60%
controls:14.36%
cases:8.96%
controls:7.43%
cases:1.97%
controls:1.16%
cases:1.85%
controls:0.08%
cases:1.56%
controls:1.16%
cases:9.53%
controls:7.53%
cases:25.03%
controls:21.30%
287
2483
1442
14807
155
1285
1574
16005
34
201
1695
17089
32
13
1697
17277
27
200
1702
17062
161
1268
1529
15565
376
3159
1126
11672
Chronic tonsillitis
J35.0 [45548113]
J35.0 [45548113]
1.4e+00
2.1e+00
—
—
—
—
7.4e-01
cases:0.81%
controls:0.21%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.22%
14
36
1715
17254
7
9
1722
17281
—
—
—
—
7
33
1495
14798
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
6.8e-01
9.3e-01
—
—
—
9.9e-01
8.2e-01
cases:3.53%
controls:1.83%
cases:1.45%
controls:0.58%
—
—
—
—
—
—
cases:1.72%
controls:0.64%
cases:5.59%
controls:2.55%
61
316
1668
16974
25
100
1704
17190
—
—
—
29
108
1661
16725
84
378
1418
14453
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
4.9e-01
8.3e-01
8.5e-01
—
1.4e+00
1.2e+00
9.2e-01
cases:7.17%
controls:4.52%
cases:2.95%
controls:1.31%
cases:0.40%
controls:0.17%
—
—
cases:0.52%
controls:0.13%
cases:3.37%
controls:1.08%
cases:6.52%
controls:2.72%
124
781
1605
16509
51
227
1678
17063
7
30
1722
17260
—
9
23
1720
17239
57
182
1633
16651
98
403
1404
14428
Mild cognitive disorder
F06.7 [45605450]
F06.7 [45605450]
—
-1.0e+50
—
—
—
2.0e+00
1.4e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.05%
cases:0.67%
controls:0.17%
—
0
5
1729
17285
—
—
—
6
8
1684
16825
10
25
1492
14806
Pulmonary Disease
29 [38004472]
29 [38004472]
5.2e-01
5.6e-01
9.6e-01
—
4.2e-01
8.0e-01
5.2e-01
cases:11.80%
controls:7.36%
cases:6.48%
controls:3.79%
cases:1.85%
controls:0.72%
—
—
cases:1.04%
controls:0.68%
cases:7.93%
controls:3.72%
cases:14.05%
controls:8.83%
204
1272
1525
16018
112
656
1617
16634
32
124
1697
17166
—
18
118
1711
17144
134
626
1556
16207
211
1309
1291
13522
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
4.0e-01
9.6e-01
—
—
—
1.3e+00
7.4e-01
cases:5.15%
controls:3.51%
cases:2.02%
controls:0.79%
—
—
—
—
—
—
cases:1.95%
controls:0.56%
cases:4.39%
controls:2.14%
89
607
1640
16683
35
136
1694
17154
—
—
—
33
95
1657
16738
66
317
1436
14514
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
1.2e+00
—
—
—
—
2.1e+00
1.3e+00
cases:0.46%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
cases:0.80%
controls:0.23%
8
24
1721
17266
—
—
—
—
9
11
1681
16822
12
34
1490
14797
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
4.1e-01
4.4e-01
9.4e-02
1.8e+00
4.8e-01
3.2e-01
4.1e-01
cases:21.98%
controls:15.69%
cases:12.78%
controls:8.62%
cases:1.97%
controls:1.79%
cases:0.40%
controls:0.07%
cases:2.78%
controls:1.74%
cases:11.78%
controls:8.85%
cases:26.96%
controls:19.65%
380
2712
1349
14578
221
1490
1508
15800
34
310
1695
16980
7
12
1722
17278
48
301
1681
16961
199
1490
1491
15343
405
2915
1097
11916
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
7.3e-01
9.2e-01
1.3e+00
—
—
9.3e-01
7.5e-01
cases:5.15%
controls:2.54%
cases:1.91%
controls:0.77%
cases:0.35%
controls:0.10%
—
—
—
—
cases:2.01%
controls:0.80%
cases:6.32%
controls:3.09%
89
439
1640
16851
33
133
1696
17157
6
17
1723
17273
—
—
34
135
1656
16698
95
459
1407
14372
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
1.2e+00
—
—
—
—
2.1e+00
1.2e+00
cases:0.46%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
cases:0.80%
controls:0.24%
8
25
1721
17265
—
—
—
—
9
11
1681
16822
12
35
1490
14796
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
5.4e-01
7.4e-01
—
—
-1.0e+50
2.0e+00
1.3e+00
cases:0.75%
controls:0.44%
cases:0.29%
controls:0.14%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.53%
controls:0.07%
cases:1.46%
controls:0.40%
13
76
1716
17214
5
24
1724
17266
—
—
0
5
1729
17257
9
12
1681
16821
22
60
1480
14771
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
8.6e-02
4.0e-01
5.6e-01
1.8e+00
1.8e-01
3.2e-01
2.2e-01
cases:34.82%
controls:32.90%
cases:35.80%
controls:27.17%
cases:9.37%
controls:5.58%
cases:1.27%
controls:0.21%
cases:6.42%
controls:5.41%
cases:35.15%
controls:28.20%
cases:56.79%
controls:51.42%
602
5688
1127
11602
619
4697
1110
12593
162
965
1567
16325
22
37
1707
17253
111
934
1618
16328
594
4747
1096
12086
853
7626
649
7205
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
3.6e-01
9.1e-01
5.6e-01
—
1.1e+00
6.7e-01
5.7e-01
cases:5.49%
controls:3.90%
cases:4.86%
controls:2.02%
cases:0.64%
controls:0.36%
—
—
cases:0.87%
controls:0.28%
cases:4.50%
controls:2.35%
cases:10.85%
controls:6.41%
95
675
1634
16615
84
349
1645
16941
11
63
1718
17227
—
15
49
1714
17213
76
395
1614
16438
163
951
1339
13880
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
9.7e-02
4.1e-01
5.6e-01
1.8e+00
1.7e-01
3.3e-01
2.1e-01
cases:35.16%
controls:33.00%
cases:35.97%
controls:27.25%
cases:9.43%
controls:5.60%
cases:1.27%
controls:0.22%
cases:6.42%
controls:5.46%
cases:35.33%
controls:28.29%
cases:56.86%
controls:51.53%
608
5705
1121
11585
622
4712
1107
12578
163
969
1566
16321
22
38
1707
17252
111
942
1618
16320
597
4762
1093
12071
854
7642
648
7189
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
8.9e-02
4.0e-01
5.6e-01
1.8e+00
1.8e-01
3.2e-01
2.1e-01
cases:34.99%
controls:32.99%
cases:35.80%
controls:27.22%
cases:9.43%
controls:5.60%
cases:1.27%
controls:0.22%
cases:6.42%
controls:5.43%
cases:35.21%
controls:28.24%
cases:56.79%
controls:51.51%
605
5704
1124
11586
619
4706
1110
12584
163
969
1566
16321
22
38
1707
17252
111
938
1618
16324
595
4753
1095
12080
853
7640
649
7191
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
8.9e-02
4.0e-01
5.6e-01
1.8e+00
1.7e-01
3.2e-01
2.1e-01
cases:34.99%
controls:32.98%
cases:35.86%
controls:27.24%
cases:9.43%
controls:5.60%
cases:1.27%
controls:0.22%
cases:6.42%
controls:5.45%
cases:35.21%
controls:28.25%
cases:56.79%
controls:51.53%
605
5703
1124
11587
620
4710
1109
12580
163
969
1566
16321
22
38
1707
17252
111
940
1618
16322
595
4756
1095
12077
853
7643
649
7188
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
8.9e-02
4.0e-01
5.6e-01
1.8e+00
1.9e-01
3.2e-01
2.1e-01
cases:34.99%
controls:32.98%
cases:35.86%
controls:27.26%
cases:9.43%
controls:5.60%
cases:1.27%
controls:0.22%
cases:6.54%
controls:5.45%
cases:35.21%
controls:28.27%
cases:56.79%
controls:51.50%
605
5703
1124
11587
620
4713
1109
12577
163
969
1566
16321
22
38
1707
17252
113
941
1616
16321
595
4759
1095
12074
853
7638
649
7193
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
9.1e-02
4.0e-01
5.6e-01
1.8e+00
1.8e-01
3.2e-01
2.1e-01
cases:34.93%
controls:32.90%
cases:35.74%
controls:27.19%
cases:9.43%
controls:5.60%
cases:1.27%
controls:0.22%
cases:6.42%
controls:5.44%
cases:35.15%
controls:28.22%
cases:56.79%
controls:51.49%
604
5688
1125
11602
618
4702
1111
12588
163
968
1566
16322
22
38
1707
17252
111
939
1618
16323
594
4751
1096
12082
853
7636
649
7195
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
8.6e-02
4.0e-01
5.6e-01
1.8e+00
1.7e-01
3.2e-01
2.1e-01
cases:34.93%
controls:33.01%
cases:35.92%
controls:27.29%
cases:9.43%
controls:5.61%
cases:1.27%
controls:0.22%
cases:6.42%
controls:5.48%
cases:35.27%
controls:28.31%
cases:56.86%
controls:51.60%
604
5707
1125
11583
621
4718
1108
12572
163
970
1566
16320
22
38
1707
17252
111
946
1618
16316
596
4765
1094
12068
854
7653
648
7178
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
7.6e-01
7.7e-01
8.9e-01
—
8.9e-01
9.0e-01
8.3e-01
cases:2.72%
controls:1.30%
cases:1.45%
controls:0.68%
cases:0.52%
controls:0.21%
—
—
cases:0.46%
controls:0.19%
cases:1.95%
controls:0.80%
cases:3.66%
controls:1.62%
47
224
1682
17066
25
117
1704
17173
9
37
1720
17253
—
8
33
1721
17229
33
135
1657
16698
55
241
1447
14590
Dentistry
C5 [903277]
C5 [903277]
5.1e-01
1.1e+00
8.4e-01
—
1.2e+00
9.8e-01
6.1e-01
cases:3.01%
controls:1.83%
cases:1.85%
controls:0.62%
cases:0.35%
controls:0.15%
—
—
cases:0.52%
controls:0.16%
cases:1.95%
controls:0.74%
cases:3.79%
controls:2.09%
52
316
1677
16974
32
108
1697
17182
6
26
1723
17264
—
9
27
1720
17235
33
125
1657
16708
57
310
1445
14521
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
7.0e-01
1.1e+00
—
—
—
6.8e-01
7.6e-01
cases:6.94%
controls:3.57%
cases:2.95%
controls:1.05%
—
—
—
—
—
—
cases:1.95%
controls:1.00%
cases:8.59%
controls:4.21%
120
617
1609
16673
51
181
1678
17109
—
—
—
33
168
1657
16665
129
624
1373
14207
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
5.7e-01
1.0e+00
—
1.0e+50
1.3e+00
8.4e-01
7.5e-01
cases:3.59%
controls:2.05%
cases:1.97%
controls:0.73%
—
—
cases:0.52%
controls:0.00%
cases:0.35%
controls:0.10%
cases:1.48%
controls:0.64%
cases:2.66%
controls:1.27%
62
355
1667
16935
34
127
1695
17163
—
9
0
1720
17290
6
17
1723
17245
25
108
1665
16725
40
189
1462
14642
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.4e-01
5.4e-01
6.3e-01
1.7e+00
6.3e-01
5.1e-01
5.1e-01
cases:12.26%
controls:9.08%
cases:9.20%
controls:5.58%
cases:1.97%
controls:1.05%
cases:0.40%
controls:0.08%
cases:1.97%
controls:1.05%
cases:9.41%
controls:5.87%
cases:20.91%
controls:13.74%
212
1570
1517
15720
159
965
1570
16325
34
182
1695
17108
7
13
1722
17277
34
182
1695
17080
159
988
1531
15845
314
2038
1188
12793
Other allergic rhinitis
J30.3 [45538477]
J30.3 [45538477]
1.2e+00
1.6e+00
—
1.0e+50
—
2.0e+00
7.2e-01
cases:0.87%
controls:0.27%
cases:0.40%
controls:0.08%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.47%
controls:0.07%
cases:0.73%
controls:0.36%
15
47
1714
17243
7
14
1722
17276
—
5
0
1724
17290
—
8
11
1682
16822
11
53
1491
14778
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.6e-01
6.4e-01
—
—
—
1.1e+00
8.7e-01
cases:10.12%
controls:6.03%
cases:3.30%
controls:1.76%
—
—
—
—
—
—
cases:3.67%
controls:1.29%
cases:8.39%
controls:3.70%
175
1042
1554
16248
57
304
1672
16986
—
—
—
62
217
1628
16616
126
549
1376
14282
cefuroxime; oral, parenteral
J01DC02 [21602884]
J01DC02 [21602884]
2.8e-01
1.5e+00
—
—
—
1.7e+00
5.3e-01
cases:1.33%
controls:1.01%
cases:0.75%
controls:0.17%
—
—
—
—
—
—
cases:0.53%
controls:0.10%
cases:0.87%
controls:0.51%
23
174
1706
17116
13
30
1716
17260
—
—
—
9
17
1681
16816
13
76
1489
14755
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
5.7e-01
—
—
—
—
3.1e+00
9.1e-01
cases:0.52%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.03%
cases:0.47%
controls:0.19%
9
51
1720
17239
—
—
—
—
11
5
1679
16828
7
28
1495
14803
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.0e+00
6.4e-01
—
—
1.6e+00
1.3e+00
8.0e-01
cases:1.68%
controls:0.62%
cases:0.58%
controls:0.31%
—
—
—
—
cases:0.35%
controls:0.07%
cases:0.89%
controls:0.25%
cases:1.60%
controls:0.72%
29
107
1700
17183
10
53
1719
17237
—
—
6
12
1723
17250
15
42
1675
16791
24
107
1478
14724
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
2.9e-01
5.5e-01
8.3e-01
—
6.5e-01
3.8e-01
3.8e-01
cases:27.18%
controls:21.76%
cases:21.34%
controls:13.56%
cases:4.22%
controls:1.89%
—
—
cases:2.83%
controls:1.51%
cases:19.11%
controls:13.95%
cases:44.27%
controls:35.24%
470
3762
1259
13528
369
2344
1360
14946
73
327
1656
16963
—
49
260
1680
17002
323
2349
1367
14484
665
5226
837
9605
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.7e-01
6.6e-01
1.1e+00
—
5.6e-01
5.3e-01
4.0e-01
cases:7.17%
controls:5.07%
cases:3.99%
controls:2.10%
cases:0.75%
controls:0.25%
—
—
cases:0.40%
controls:0.23%
cases:3.91%
controls:2.33%
cases:12.45%
controls:8.72%
124
877
1605
16413
69
363
1660
16927
13
44
1716
17246
—
7
40
1722
17222
66
393
1624
16440
187
1294
1315
13537
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
3.3e-01
5.8e-01
7.0e-01
—
6.8e-01
3.4e-01
3.9e-01
cases:21.86%
controls:16.76%
cases:16.08%
controls:9.69%
cases:2.72%
controls:1.37%
—
—
cases:2.20%
controls:1.12%
cases:13.55%
controls:10.03%
cases:34.89%
controls:26.62%
378
2897
1351
14393
278
1675
1451
15615
47
237
1682
17053
—
38
194
1691
17068
229
1688
1461
15145
524
3948
978
10883
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
4.6e-01
6.9e-01
8.7e-01
—
7.3e-01
5.2e-01
4.6e-01
cases:9.25%
controls:6.04%
cases:7.11%
controls:3.71%
cases:1.10%
controls:0.46%
—
—
cases:0.98%
controls:0.48%
cases:6.75%
controls:4.11%
cases:17.84%
controls:12.10%
160
1044
1569
16246
123
642
1606
16648
19
80
1710
17210
—
17
82
1712
17180
114
692
1576
16141
268
1795
1234
13036
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
6.6e-01
7.7e-01
8.0e-01
—
9.5e-01
8.9e-01
6.8e-01
cases:4.80%
controls:2.54%
cases:2.54%
controls:1.20%
cases:0.46%
controls:0.21%
—
—
cases:0.52%
controls:0.20%
cases:2.84%
controls:1.19%
cases:6.72%
controls:3.53%
83
440
1646
16850
44
207
1685
17083
8
36
1721
17254
—
9
35
1720
17227
48
200
1642
16633
101
524
1401
14307
Allergy, unspecified
T78.4 [45580373]
T78.4 [45580373]
1.0e+00
1.4e+00
—
—
—
1.9e+00
6.8e-01
cases:1.10%
controls:0.39%
cases:0.40%
controls:0.10%
—
—
—
—
—
—
cases:0.53%
controls:0.08%
cases:0.67%
controls:0.34%
19
67
1710
17223
7
18
1722
17272
—
—
—
9
13
1681
16820
10
50
1492
14781
Facial pain NOS
R51.81 [2000503604]
R51.81 [2000503604]
1.4e+00
—
—
—
—
1.9e+00
1.6e+00
cases:0.58%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.05%
cases:0.67%
controls:0.14%
10
24
1719
17266
—
—
—
—
6
9
1684
16824
10
21
1492
14810
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
6.5e-01
9.2e-01
—
1.0e+50
—
1.2e+00
1.1e+00
cases:2.78%
controls:1.47%
cases:0.81%
controls:0.32%
—
—
cases:0.75%
controls:0.00%
—
—
cases:1.36%
controls:0.40%
cases:4.39%
controls:1.50%
48
254
1681
17036
14
56
1715
17234
—
13
0
1716
17290
—
23
68
1667
16765
66
222
1436
14609
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
6.6e-01
8.0e-01
1.5e+00
—
8.7e-01
7.7e-01
7.4e-01
cases:6.59%
controls:3.53%
cases:2.49%
controls:1.13%
cases:0.40%
controls:0.09%
—
—
cases:0.29%
controls:0.12%
cases:2.19%
controls:1.03%
cases:8.12%
controls:4.03%
114
610
1615
16680
43
196
1686
17094
7
15
1722
17275
—
5
21
1724
17241
37
173
1653
16660
122
598
1380
14233
Cough
R05 [45606792]
R05 [45606792]
7.6e-01
7.7e-01
1.3e+00
—
—
7.9e-01
6.2e-01
cases:4.45%
controls:2.13%
cases:1.56%
controls:0.73%
cases:0.29%
controls:0.08%
—
—
—
—
cases:1.54%
controls:0.71%
cases:5.33%
controls:2.93%
77
368
1652
16922
27
126
1702
17164
5
14
1724
17276
—
—
26
119
1664
16714
80
435
1422
14396
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
4.7e-02
3.0e-01
5.4e-01
1.8e+00
2.6e-01
2.8e-01
1.2e-01
cases:25.68%
controls:24.80%
cases:23.83%
controls:18.81%
cases:6.30%
controls:3.78%
cases:0.93%
controls:0.15%
cases:4.51%
controls:3.52%
cases:24.02%
controls:19.33%
cases:41.61%
controls:38.82%
444
4288
1285
13002
412
3252
1317
14038
109
654
1620
16636
16
26
1713
17264
78
608
1651
16654
406
3254
1284
13579
625
5758
877
9073
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
5.0e-01
1.0e+00
1.3e+00
—
1.0e+00
8.2e-01
6.1e-01
cases:3.59%
controls:2.20%
cases:2.95%
controls:1.11%
cases:0.58%
controls:0.16%
—
—
cases:0.35%
controls:0.13%
cases:2.19%
controls:0.97%
cases:6.92%
controls:3.89%
62
381
1667
16909
51
192
1678
17098
10
27
1719
17263
—
6
22
1723
17240
37
164
1653
16669
104
577
1398
14254
Abnormal weight loss
R63.4 [45568144]
R63.4 [45568144]
1.2e+00
1.7e+00
—
—
—
1.5e+00
8.4e-01
cases:0.75%
controls:0.22%
cases:0.46%
controls:0.09%
—
—
—
—
—
—
cases:0.30%
controls:0.07%
cases:0.67%
controls:0.29%
13
38
1716
17252
8
15
1721
17275
—
—
—
5
11
1685
16822
10
43
1492
14788
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
6.7e-01
6.9e-01
3.5e-01
—
4.1e-01
7.8e-01
7.5e-01
cases:7.29%
controls:3.86%
cases:3.82%
controls:1.94%
cases:0.69%
controls:0.49%
—
—
cases:0.81%
controls:0.54%
cases:4.38%
controls:2.05%
cases:8.72%
controls:4.32%
126
667
1603
16623
66
336
1663
16954
12
85
1717
17205
—
14
93
1715
17169
74
345
1616
16488
131
640
1371
14191
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
8.1e-02
2.8e-01
4.9e-01
1.8e+00
2.1e-01
3.2e-01
1.8e-01
cases:21.63%
controls:20.29%
cases:20.47%
controls:16.23%
cases:5.49%
controls:3.44%
cases:0.87%
controls:0.14%
cases:3.93%
controls:3.20%
cases:21.42%
controls:16.59%
cases:36.95%
controls:32.96%
374
3509
1355
13781
354
2806
1375
14484
95
595
1634
16695
15
25
1714
17265
68
553
1661
16709
362
2792
1328
14041
555
4888
947
9943
levocetirizine; oral
R06AE09 [21603498]
R06AE09 [21603498]
6.3e-01
7.0e-01
8.8e-01
—
7.6e-01
8.6e-01
6.8e-01
cases:3.88%
controls:2.10%
cases:1.68%
controls:0.84%
cases:0.35%
controls:0.14%
—
—
cases:0.35%
controls:0.16%
cases:1.89%
controls:0.81%
cases:3.40%
controls:1.75%
67
363
1662
16927
29
145
1700
17145
6
25
1723
17265
—
6
28
1723
17234
32
137
1658
16696
51
260
1451
14571
Wheezing
R06.2 [45548946]
R06.2 [45548946]
7.9e-01
—
—
—
—
1.8e+00
1.1e+00
cases:0.64%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.07%
cases:0.93%
controls:0.32%
11
50
1718
17240
—
—
—
—
7
12
1683
16821
14
47
1488
14784
Abdominal pain/cramps general
D01 [2002000300]
D01 [2002000300]
6.7e-01
8.8e-01
—
—
—
1.1e+00
1.1e+00
cases:2.02%
controls:1.05%
cases:0.69%
controls:0.29%
—
—
—
—
—
—
cases:0.89%
controls:0.30%
cases:3.60%
controls:1.23%
35
181
1694
17109
12
50
1717
17240
—
—
—
15
51
1675
16782
54
183
1448
14648
bupropion; oral
N06AX12 [21604741]
N06AX12 [21604741]
4.8e-01
1.0e+00
—
—
1.1e+00
1.0e+00
7.9e-01
cases:1.21%
controls:0.76%
cases:1.27%
controls:0.45%
—
—
—
—
cases:0.35%
controls:0.12%
cases:1.07%
controls:0.39%
cases:2.13%
controls:0.98%
21
131
1708
17159
22
78
1707
17212
—
—
6
20
1723
17242
18
66
1672
16767
32
145
1470
14686
Migraine
N89 [2002000789]
N89 [2002000789]
4.4e-01
1.6e+00
—
—
—
1.3e+00
1.2e+00
cases:0.40%
controls:0.26%
cases:0.52%
controls:0.10%
—
—
—
—
—
—
cases:0.30%
controls:0.08%
cases:1.00%
controls:0.30%
7
45
1722
17245
9
18
1720
17272
—
—
—
5
14
1685
16819
15
44
1487
14787
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
5.3e-01
8.4e-01
—
1.0e+50
1.1e+00
1.0e+00
9.7e-01
cases:2.14%
controls:1.27%
cases:1.21%
controls:0.53%
—
—
cases:0.29%
controls:0.00%
cases:0.29%
controls:0.10%
cases:1.36%
controls:0.50%
cases:3.60%
controls:1.39%
37
219
1692
17071
21
91
1708
17199
—
5
0
1724
17290
5
17
1724
17245
23
84
1667
16749
54
206
1448
14625
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
4.3e-01
7.2e-01
5.4e-01
—
1.1e+00
4.3e-01
5.9e-01
cases:10.87%
controls:7.35%
cases:4.28%
controls:2.14%
cases:0.35%
controls:0.20%
—
—
cases:0.75%
controls:0.25%
cases:3.20%
controls:2.11%
cases:11.19%
controls:6.53%
188
1271
1541
16019
74
370
1655
16920
6
35
1723
17255
—
13
44
1716
17218
54
355
1636
16478
168
968
1334
13863
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
4.3e-01
7.2e-01
5.4e-01
—
1.1e+00
4.3e-01
5.9e-01
cases:10.87%
controls:7.35%
cases:4.28%
controls:2.14%
cases:0.35%
controls:0.20%
—
—
cases:0.75%
controls:0.25%
cases:3.20%
controls:2.11%
cases:11.19%
controls:6.53%
188
1271
1541
16019
74
370
1655
16920
6
35
1723
17255
—
13
44
1716
17218
54
355
1636
16478
168
968
1334
13863
Audiometric test
21727005 [4071702]
21727005 [4071702]
4.5e-01
8.8e-01
—
—
—
1.1e+00
8.3e-01
cases:2.31%
controls:1.49%
cases:1.21%
controls:0.51%
—
—
—
—
—
—
cases:1.36%
controls:0.47%
cases:3.93%
controls:1.75%
40
257
1689
17033
21
88
1708
17202
—
—
—
23
79
1667
16754
59
259
1443
14572
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.4e-01
6.3e-01
8.2e-01
—
4.2e-01
4.6e-01
5.4e-01
cases:19.61%
controls:14.77%
cases:14.05%
controls:8.03%
cases:2.49%
controls:1.12%
—
—
cases:1.50%
controls:1.00%
cases:11.78%
controls:7.75%
cases:32.69%
controls:22.14%
339
2553
1390
14737
243
1389
1486
15901
43
193
1686
17097
—
26
172
1703
17090
199
1304
1491
15529
491
3284
1011
11547
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
6.1e-01
6.5e-01
—
—
6.9e-01
8.3e-01
6.5e-01
cases:6.94%
controls:3.91%
cases:2.83%
controls:1.50%
—
—
—
—
cases:0.35%
controls:0.17%
cases:3.20%
controls:1.42%
cases:10.12%
controls:5.54%
120
676
1609
16614
49
260
1680
17030
—
—
6
30
1723
17232
54
239
1636
16594
152
822
1350
14009
Cervicobrachial syndrome
M53.1 [45567577]
M53.1 [45567577]
7.4e-01
1.1e+00
—
—
—
5.2e-01
9.3e-01
cases:2.49%
controls:1.20%
cases:1.04%
controls:0.36%
—
—
—
—
—
—
cases:0.71%
controls:0.42%
cases:3.86%
controls:1.56%
43
208
1686
17082
18
63
1711
17227
—
—
—
12
71
1678
16762
58
232
1444
14599
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
14913-8 [3017446]
7.6e-01
1.1e+00
—
—
—
7.1e-01
7.7e-01
cases:1.97%
controls:0.93%
cases:1.33%
controls:0.43%
—
—
—
—
—
—
cases:1.18%
controls:0.59%
cases:3.00%
controls:1.42%
34
160
1695
17130
23
74
1706
17216
—
—
—
20
99
1670
16734
45
210
1457
14621
propranolol; oral, parenteral
C07AA05 [21601670]
C07AA05 [21601670]
4.6e-01
5.6e-01
2.5e-01
—
1.1e+00
4.6e-01
5.5e-01
cases:6.19%
controls:4.01%
cases:3.59%
controls:2.08%
cases:0.58%
controls:0.45%
—
—
cases:1.16%
controls:0.39%
cases:3.37%
controls:2.16%
cases:7.72%
controls:4.61%
107
694
1622
16596
62
359
1667
16931
10
78
1719
17212
—
20
68
1709
17194
57
363
1633
16470
116
684
1386
14147
Chronic pansinusitis
J32.4 [45581854]
J32.4 [45581854]
—
—
—
—
—
2.6e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:0.47%
controls:0.13%
—
—
—
—
—
11
8
1679
16825
7
20
1495
14811
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
3.1e-01
9.5e-01
-1.0e+50
—
—
1.6e+00
1.1e+00
cases:0.87%
controls:0.64%
cases:0.58%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.65%
controls:0.14%
cases:2.06%
controls:0.73%
15
110
1714
17180
10
39
1719
17251
0
5
1729
17285
—
—
11
23
1679
16810
31
108
1471
14723
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
4.8e-01
8.4e-01
6.5e-01
—
7.3e-01
6.0e-01
7.0e-01
cases:7.35%
controls:4.68%
cases:5.03%
controls:2.24%
cases:0.98%
controls:0.51%
—
—
cases:0.93%
controls:0.45%
cases:4.08%
controls:2.28%
cases:8.92%
controls:4.65%
127
810
1602
16480
87
387
1642
16903
17
89
1712
17201
—
16
77
1713
17185
69
383
1621
16450
134
690
1368
14141
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
2.8e-01
9.0e-01
1.1e+00
—
-1.0e+50
1.1e+00
6.2e-01
cases:1.68%
controls:1.27%
cases:1.39%
controls:0.57%
cases:0.29%
controls:0.09%
—
—
cases:0.00%
controls:0.07%
cases:1.42%
controls:0.48%
cases:3.06%
controls:1.68%
29
219
1700
17071
24
98
1705
17192
5
16
1724
17274
—
0
12
1729
17250
24
81
1666
16752
46
249
1456
14582
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
4.5e-01
8.3e-01
3.3e-01
—
6.1e-01
7.7e-01
5.6e-01
cases:4.80%
controls:3.13%
cases:3.93%
controls:1.75%
cases:0.58%
controls:0.42%
—
—
cases:0.75%
controls:0.41%
cases:3.73%
controls:1.76%
cases:5.73%
controls:3.35%
83
541
1646
16749
68
303
1661
16987
10
72
1719
17218
—
13
71
1716
17191
63
296
1627
16537
86
497
1416
14334
Orthopedic Surgery
20 [38004465]
20 [38004465]
4.2e-01
4.8e-01
7.3e-01
—
2.5e-01
4.9e-01
4.9e-01
cases:19.55%
controls:13.81%
cases:8.27%
controls:5.30%
cases:1.74%
controls:0.84%
—
—
cases:1.21%
controls:0.95%
cases:8.52%
controls:5.42%
cases:23.30%
controls:15.73%
338
2388
1391
14902
143
917
1586
16373
30
146
1699
17144
—
21
164
1708
17098
144
912
1546
15921
350
2333
1152
12498
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
2.0e-01
9.6e-01
1.6e+00
—
1.5e+00
8.4e-01
7.9e-01
cases:2.60%
controls:2.14%
cases:2.08%
controls:0.80%
cases:0.29%
controls:0.06%
—
—
cases:0.35%
controls:0.08%
cases:1.54%
controls:0.67%
cases:5.59%
controls:2.62%
45
370
1684
16920
36
139
1693
17151
5
10
1724
17280
—
6
13
1723
17249
26
113
1664
16720
84
388
1418
14443
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
6.4e-01
7.4e-01
8.8e-01
—
1.4e+00
6.8e-01
5.3e-01
cases:2.78%
controls:1.48%
cases:2.37%
controls:1.15%
cases:0.35%
controls:0.14%
—
—
cases:0.52%
controls:0.13%
cases:2.66%
controls:1.37%
cases:8.66%
controls:5.27%
48
256
1681
17034
41
198
1688
17092
6
25
1723
17265
—
9
23
1720
17239
45
231
1645
16602
130
781
1372
14050
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
3.9e-01
6.3e-01
4.2e-01
—
—
9.7e-01
5.8e-01
cases:7.58%
controls:5.28%
cases:2.43%
controls:1.31%
cases:0.29%
controls:0.19%
—
—
—
—
cases:2.84%
controls:1.09%
cases:6.19%
controls:3.56%
131
913
1598
16377
42
227
1687
17063
5
33
1724
17257
—
—
48
184
1642
16649
93
528
1409
14303
Laboratory test
15220000 [4034850]
15220000 [4034850]
4.8e-01
5.7e-01
1.0e+00
—
1.5e+00
1.1e+00
4.0e-02
cases:3.12%
controls:1.96%
cases:1.68%
controls:0.96%
cases:0.35%
controls:0.13%
—
—
cases:0.64%
controls:0.14%
cases:3.14%
controls:1.09%
cases:4.39%
controls:4.23%
54
339
1675
16951
29
166
1700
17124
6
22
1723
17268
—
11
25
1718
17237
53
184
1637
16649
66
627
1436
14204
Sneezing/nasal congestion
R07 [2002000888]
R07 [2002000888]
8.2e-01
1.7e+00
-1.0e+50
—
-1.0e+50
4.1e-01
8.2e-01
cases:1.39%
controls:0.62%
cases:0.98%
controls:0.17%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.03%
cases:0.30%
controls:0.20%
cases:1.33%
controls:0.59%
24
107
1705
17183
17
30
1712
17260
0
5
1729
17285
—
0
6
1729
17256
5
33
1685
16800
20
88
1482
14743
Tonsillectomy
EMB10 [2001302265]
EMB10 [2001302265]
4.7e-01
2.5e+00
—
—
—
—
7.4e-01
cases:0.40%
controls:0.25%
cases:0.58%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.22%
7
44
1722
17246
10
8
1719
17282
—
—
—
—
7
33
1495
14798
Rheumatology
66 [38004491]
66 [38004491]
4.8e-01
6.2e-01
5.1e-01
—
2.7e-01
6.6e-01
7.7e-01
cases:5.26%
controls:3.31%
cases:3.70%
controls:2.03%
cases:0.75%
controls:0.45%
—
—
cases:0.52%
controls:0.40%
cases:3.61%
controls:1.90%
cases:7.32%
controls:3.55%
91
573
1638
16717
64
351
1665
16939
13
78
1716
17212
—
9
69
1720
17193
61
319
1629
16514
110
526
1392
14305
Dysphagia
R13 [45573013]
R13 [45573013]
8.9e-01
7.4e-01
—
1.0e+50
—
1.4e+00
1.2e+00
cases:0.93%
controls:0.38%
cases:0.29%
controls:0.14%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.71%
controls:0.18%
cases:1.53%
controls:0.49%
16
66
1713
17224
5
24
1724
17266
—
5
0
1724
17290
—
12
31
1678
16802
23
72
1479
14759
Knee and lower leg MRI examination with high intensity magnet
NG1BG [2001308056]
NG1BG [2001308056]
9.2e-01
—
—
—
—
2.5e+00
8.7e-01
cases:0.64%
controls:0.25%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:0.87%
controls:0.36%
11
44
1718
17246
—
—
—
—
11
9
1679
16824
13
54
1489
14777
Other otitis externa
H60.8 [45567109]
H60.8 [45567109]
4.9e-01
2.5e+00
—
—
—
—
6.5e-01
cases:0.40%
controls:0.25%
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.24%
7
43
1722
17247
6
5
1723
17285
—
—
—
—
7
36
1495
14795
Removal of stent from ureter
KBV10 [2001305893]
KBV10 [2001305893]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
—
—
—
—
—
—
6
5
1496
14826
Fear of neurological disease other
N27 [2002000732]
N27 [2002000732]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
—
—
—
—
—
—
6
5
1496
14826
Mouth breathing
R06.5 [45573006]
R06.5 [45573006]
6.7e-01
1.3e+00
—
—
—
1.4e+00
1.0e+00
cases:1.21%
controls:0.62%
cases:0.52%
controls:0.14%
—
—
—
—
—
—
cases:0.59%
controls:0.14%
cases:1.86%
controls:0.68%
21
108
1708
17182
9
24
1720
17266
—
—
—
10
24
1680
16809
28
101
1474
14730
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
6.3e-01
6.0e-01
1.7e-01
—
—
6.7e-01
5.5e-01
cases:7.23%
controls:3.98%
cases:2.72%
controls:1.52%
cases:0.29%
controls:0.24%
—
—
—
—
cases:2.37%
controls:1.22%
cases:6.66%
controls:3.96%
125
689
1604
16601
47
262
1682
17028
5
42
1724
17248
—
—
40
206
1650
16627
100
588
1402
14243
Aortic (valve) insufficiency
I35.1 [45572087]
I35.1 [45572087]
6.6e-01
1.4e+00
—
—
—
9.4e-01
1.1e+00
cases:0.81%
controls:0.42%
cases:0.69%
controls:0.18%
—
—
—
—
—
—
cases:0.65%
controls:0.26%
cases:2.00%
controls:0.70%
14
73
1715
17217
12
31
1717
17259
—
—
—
11
43
1679
16790
30
104
1472
14727
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
6.5e-01
7.6e-01
—
—
—
1.6e+00
8.3e-01
cases:0.87%
controls:0.46%
cases:0.35%
controls:0.16%
—
—
—
—
—
—
cases:0.65%
controls:0.14%
cases:1.73%
controls:0.76%
15
79
1714
17211
6
28
1723
17262
—
—
—
11
23
1679
16810
26
113
1476
14718
Allergic rhinitis due to pollen
J30.10 [2000502594]
J30.10 [2000502594]
9.9e-01
1.2e+00
-1.0e+50
—
—
1.4e+00
7.3e-01
cases:1.16%
controls:0.43%
cases:0.40%
controls:0.12%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.59%
controls:0.15%
cases:1.00%
controls:0.49%
20
75
1709
17215
7
21
1722
17269
0
5
1729
17285
—
—
10
25
1680
16808
15
72
1487
14759
Examination of ears and hearing
Z01.1 [45547279]
Z01.1 [45547279]
6.6e-01
6.7e-01
—
1.0e+50
1.8e+00
1.1e+00
6.2e-01
cases:2.14%
controls:1.12%
cases:0.87%
controls:0.45%
—
—
cases:0.75%
controls:0.00%
cases:0.35%
controls:0.06%
cases:1.36%
controls:0.46%
cases:2.60%
controls:1.41%
37
193
1692
17097
15
77
1714
17213
—
13
0
1716
17290
6
10
1723
17252
23
78
1667
16755
39
209
1463
14622
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
4.5e-01
1.2e+00
1.7e+00
—
—
5.4e-01
7.0e-01
cases:3.88%
controls:2.51%
cases:2.43%
controls:0.73%
cases:0.29%
controls:0.05%
—
—
—
—
cases:1.12%
controls:0.66%
cases:4.99%
controls:2.54%
67
434
1662
16856
42
127
1687
17163
5
9
1724
17281
—
—
19
111
1671
16722
75
376
1427
14455
hydroxychloroquine; oral
P01BA02 [21604889]
P01BA02 [21604889]
7.7e-01
7.3e-01
5.8e-01
—
—
5.3e-01
8.6e-01
cases:3.01%
controls:1.41%
cases:2.31%
controls:1.13%
cases:0.46%
controls:0.26%
—
—
—
—
cases:1.95%
controls:1.16%
cases:3.53%
controls:1.52%
52
244
1677
17046
40
196
1689
17094
8
45
1721
17245
—
—
33
196
1657
16637
53
226
1449
14605
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
5.7e-01
5.4e-01
3.9e-01
—
6.7e-01
6.7e-01
5.8e-01
cases:5.90%
controls:3.42%
cases:3.30%
controls:1.95%
cases:0.52%
controls:0.35%
—
—
cases:0.58%
controls:0.30%
cases:3.43%
controls:1.79%
cases:7.79%
controls:4.50%
102
592
1627
16698
57
338
1672
16952
9
61
1720
17229
—
10
51
1719
17211
58
302
1632
16531
117
667
1385
14164
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
7.9e-01
4.6e-01
1.4e+00
—
—
9.2e-01
6.4e-01
cases:5.15%
controls:2.41%
cases:1.45%
controls:0.91%
cases:0.40%
controls:0.10%
—
—
—
—
cases:2.01%
controls:0.81%
cases:5.93%
controls:3.21%
89
416
1640
16874
25
158
1704
17132
7
18
1722
17272
—
—
34
136
1656
16697
89
476
1413
14355
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
9.5e-01
8.4e-01
-1.0e+50
—
-1.0e+50
1.4e+00
6.4e-01
cases:0.93%
controls:0.36%
cases:0.35%
controls:0.15%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.03%
cases:0.71%
controls:0.18%
cases:0.87%
controls:0.46%
16
62
1713
17228
6
26
1723
17264
0
6
1729
17284
—
0
5
1729
17257
12
30
1678
16803
13
68
1489
14763
Cardiology
6 [38004451]
6 [38004451]
4.3e-01
5.8e-01
5.5e-01
—
8.1e-01
7.1e-01
6.0e-01
cases:11.57%
controls:7.83%
cases:6.59%
controls:3.80%
cases:1.04%
controls:0.60%
—
—
cases:1.16%
controls:0.52%
cases:6.57%
controls:3.36%
cases:16.25%
controls:9.59%
200
1354
1529
15936
114
657
1615
16633
18
104
1711
17186
—
20
89
1709
17173
111
565
1579
16268
244
1422
1258
13409
Cervical spine CT examination
NA1AD [2001306982]
NA1AD [2001306982]
4.7e-01
2.3e+00
—
—
—
—
3.8e-01
cases:0.40%
controls:0.25%
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.36%
7
44
1722
17246
6
6
1723
17284
—
—
—
—
8
54
1494
14777
Suture of skin of upper limb
QCB00 [2001309902]
QCB00 [2001309902]
2.3e+00
—
—
—
—
—
-1.0e+50
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
6
6
1723
17284
—
—
—
—
—
0
7
1502
14824
Chlamydophila sp Ab [Presence] in Serum
46179-8 [3047007]
46179-8 [3047007]
—
2.3e+00
—
—
—
-1.0e+50
3.2e-01
—
—
cases:0.35%
controls:0.03%
—
—
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.40%
controls:0.29%
—
6
6
1723
17284
—
—
—
0
8
1690
16825
6
43
1496
14788
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7817-0 [3016888]
3.4e-01
3.2e-01
—
—
1.8e+00
1.4e+00
8.6e-01
cases:1.33%
controls:0.95%
cases:0.46%
controls:0.34%
—
—
—
—
cases:0.29%
controls:0.05%
cases:1.12%
controls:0.27%
cases:2.80%
controls:1.21%
23
165
1706
17125
8
58
1721
17232
—
—
5
8
1724
17254
19
45
1671
16788
42
179
1460
14652
isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 [21600321]
C01DA08 [21600321]
5.1e-01
7.4e-01
6.1e-01
—
4.4e-01
6.7e-01
3.9e-01
cases:5.67%
controls:3.50%
cases:3.41%
controls:1.67%
cases:0.52%
controls:0.28%
—
—
cases:0.40%
controls:0.26%
cases:3.37%
controls:1.75%
cases:6.59%
controls:4.58%
98
605
1631
16685
59
288
1670
17002
9
49
1720
17241
—
7
45
1722
17217
57
294
1633
16539
99
679
1403
14152
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
5.1e-01
6.5e-01
—
—
-1.5e-01
6.3e-01
5.0e-01
cases:11.22%
controls:7.05%
cases:4.40%
controls:2.34%
—
—
—
—
cases:0.29%
controls:0.34%
cases:3.96%
controls:2.15%
cases:9.72%
controls:6.10%
194
1219
1535
16071
76
404
1653
16886
—
—
5
58
1724
17204
67
362
1623
16471
146
905
1356
13926
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
3.1e-01
1.5e+00
—
—
—
9.2e-01
8.2e-01
cases:0.69%
controls:0.51%
cases:0.75%
controls:0.17%
—
—
—
—
—
—
cases:0.47%
controls:0.19%
cases:1.46%
controls:0.65%
12
88
1717
17202
13
30
1716
17260
—
—
—
8
32
1682
16801
22
96
1480
14735
Bilateral hand X-ray examination
ND2DA [2001307619]
ND2DA [2001307619]
1.0e+00
—
—
—
—
—
2.3e+00
cases:0.29%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.06%
5
18
1724
17272
—
—
—
—
—
9
9
1493
14822
Plastic operation on acromioclavicular joint
NBG00 [2001307299]
NBG00 [2001307299]
—
-1.0e+50
—
—
—
—
2.3e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
—
0
6
1729
17284
—
—
—
—
6
6
1496
14825
Disorder of breast, unspecified
N64.9 [45558164]
N64.9 [45558164]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
—
—
—
—
—
—
6
6
1496
14825
Panniculitis affecting regions of neck and back
M54.0 [45538787]
M54.0 [45538787]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
—
—
—
—
—
—
6
6
1496
14825
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 [3009991]
12480-0 [3009991]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
—
—
—
—
—
—
6
6
1496
14825
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
6.5e-01
7.7e-01
—
—
—
4.8e-01
8.5e-01
cases:3.53%
controls:1.87%
cases:2.26%
controls:1.05%
—
—
—
—
—
—
cases:1.42%
controls:0.88%
cases:6.19%
controls:2.74%
61
323
1668
16967
39
182
1690
17108
—
—
—
24
148
1666
16685
93
406
1409
14425
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
6.1e-01
4.6e-01
8.7e-01
—
—
9.0e-01
7.6e-01
cases:8.44%
controls:4.75%
cases:2.31%
controls:1.47%
cases:0.29%
controls:0.12%
—
—
—
—
cases:3.25%
controls:1.34%
cases:10.92%
controls:5.43%
146
822
1583
16468
40
255
1689
17035
5
21
1724
17269
—
—
55
226
1635
16607
164
806
1338
14025
Respiratory symptom/complaint other
R29 [2002000898]
R29 [2002000898]
4.1e-01
1.4e+00
—
—
—
8.8e-01
8.6e-01
cases:0.93%
controls:0.61%
cases:0.64%
controls:0.16%
—
—
—
—
—
—
cases:0.41%
controls:0.17%
cases:1.46%
controls:0.63%
16
106
1713
17184
11
27
1718
17263
—
—
—
7
29
1683
16804
22
93
1480
14738
Constipation
K59.0 [45557663]
K59.0 [45557663]
1.1e+00
5.8e-01
—
—
—
1.4e+00
1.1e+00
cases:0.81%
controls:0.27%
cases:0.29%
controls:0.16%
—
—
—
—
—
—
cases:0.53%
controls:0.14%
cases:1.20%
controls:0.38%
14
46
1715
17244
5
28
1724
17262
—
—
—
9
23
1681
16810
18
57
1484
14774
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
4.5e-01
7.3e-01
—
—
4.1e-01
8.2e-01
7.1e-01
cases:3.18%
controls:2.05%
cases:1.97%
controls:0.96%
—
—
—
—
cases:0.29%
controls:0.19%
cases:2.07%
controls:0.92%
cases:7.06%
controls:3.60%
55
355
1674
16935
34
166
1695
17124
—
—
5
33
1724
17229
35
155
1655
16678
106
534
1396
14297
valaciclovir; oral
J05AB11 [21603137]
J05AB11 [21603137]
6.4e-01
8.9e-01
—
—
1.0e+00
3.4e-01
7.2e-01
cases:3.24%
controls:1.74%
cases:1.74%
controls:0.72%
—
—
—
—
cases:0.40%
controls:0.14%
cases:1.18%
controls:0.84%
cases:4.39%
controls:2.18%
56
301
1673
16989
30
124
1699
17166
—
—
7
25
1722
17237
20
142
1670
16691
66
323
1436
14508
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
3.7e-01
5.1e-01
7.2e-01
—
1.8e-01
7.3e-01
6.4e-01
cases:9.25%
controls:6.60%
cases:3.93%
controls:2.40%
cases:0.58%
controls:0.28%
—
—
cases:0.35%
controls:0.29%
cases:4.44%
controls:2.19%
cases:13.18%
controls:7.44%
160
1142
1569
16148
68
415
1661
16875
10
49
1719
17241
—
6
50
1723
17212
75
369
1615
16464
198
1104
1304
13727
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
6.4e-01
9.4e-01
—
—
—
7.2e-01
6.2e-01
cases:4.11%
controls:2.20%
cases:1.33%
controls:0.53%
—
—
—
—
—
—
cases:1.01%
controls:0.49%
cases:2.60%
controls:1.42%
71
381
1658
16909
23
91
1706
17199
—
—
—
17
83
1673
16750
39
210
1463
14621
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
1.2e+00
1.0e+00
—
—
—
9.0e-01
9.8e-01
cases:2.72%
controls:0.83%
cases:0.81%
controls:0.29%
—
—
—
—
—
—
cases:0.71%
controls:0.29%
cases:2.73%
controls:1.04%
47
143
1682
17147
14
51
1715
17239
—
—
—
12
49
1678
16784
41
154
1461
14677
Nasal polyp, unspecified
J33.9 [45567263]
J33.9 [45567263]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.07%
—
—
—
—
—
—
9
10
1493
14821
Chest pain NOS
A11 [2002000152]
A11 [2002000152]
6.5e-01
1.2e+00
—
—
—
1.2e+00
9.8e-01
cases:1.16%
controls:0.61%
cases:0.75%
controls:0.23%
—
—
—
—
—
—
cases:0.59%
controls:0.18%
cases:2.40%
controls:0.92%
20
105
1709
17185
13
39
1716
17251
—
—
—
10
31
1680
16802
36
136
1466
14695
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
3.8e-01
8.8e-01
4.1e-01
—
—
5.2e-01
3.9e-01
cases:13.07%
controls:9.29%
cases:5.32%
controls:2.28%
cases:0.46%
controls:0.31%
—
—
—
—
cases:3.61%
controls:2.18%
cases:9.52%
controls:6.64%
226
1606
1503
15684
92
394
1637
16896
8
53
1721
17237
—
—
61
367
1629
16466
143
985
1359
13846
Atypical facial pain
G50.1 [45542894]
G50.1 [45542894]
1.4e+00
2.2e+00
—
—
—
1.8e+00
7.2e-01
cases:0.40%
controls:0.10%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
cases:0.30%
controls:0.05%
cases:0.33%
controls:0.16%
7
17
1722
17273
7
8
1722
17282
—
—
—
5
8
1685
16825
5
24
1497
14807
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
3.6e-01
5.1e-01
6.8e-01
—
5.5e-01
6.7e-01
6.4e-01
cases:6.88%
controls:4.92%
cases:4.28%
controls:2.61%
cases:0.75%
controls:0.38%
—
—
cases:0.46%
controls:0.27%
cases:4.38%
controls:2.30%
cases:13.38%
controls:7.56%
119
851
1610
16439
74
451
1655
16839
13
66
1716
17224
—
8
46
1721
17216
74
387
1616
16446
201
1121
1301
13710
Lichen planus, unspecified
L43.9 [45591635]
L43.9 [45591635]
9.6e-01
—
—
—
—
2.2e+00
6.5e-01
cases:0.35%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.05%
cases:0.40%
controls:0.21%
6
23
1723
17267
—
—
—
—
7
8
1683
16825
6
31
1496
14800
Nose symptom/complaint other
R08 [2002000889]
R08 [2002000889]
5.6e-01
2.2e+00
—
—
—
—
7.9e-01
cases:0.46%
controls:0.27%
cases:0.75%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.30%
8
46
1721
17244
13
15
1716
17275
—
—
—
—
10
45
1492
14786
Flail joint
M25.2 [45567527]
M25.2 [45567527]
2.2e+00
—
—
—
—
—
—
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1723
17283
—
—
—
—
—
—
Removal of biofilm and supragingival calculus, short
SCD01 [2001310313]
SCD01 [2001310313]
2.2e+00
—
—
—
—
—
—
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1723
17283
—
—
—
—
—
—
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18500-9 [3018006]
18500-9 [3018006]
2.1e-01
3.4e-01
2.2e+00
—
—
4.9e-01
3.6e-01
cases:3.82%
controls:3.12%
cases:1.50%
controls:1.07%
cases:0.35%
controls:0.04%
—
—
—
—
cases:1.95%
controls:1.21%
cases:6.13%
controls:4.37%
66
539
1663
16751
26
185
1703
17105
6
7
1723
17283
—
—
33
203
1657
16630
92
648
1410
14183
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
5.2e-01
6.4e-01
7.2e-01
1.0e+50
6.5e-01
5.5e-01
4.4e-01
cases:5.38%
controls:3.28%
cases:2.78%
controls:1.48%
cases:0.46%
controls:0.23%
cases:0.29%
controls:0.00%
cases:0.52%
controls:0.27%
cases:3.02%
controls:1.76%
cases:8.85%
controls:5.91%
93
567
1636
16723
48
256
1681
17034
8
39
1721
17251
5
0
1724
17290
9
47
1720
17215
51
296
1639
16537
133
877
1369
13954
Other candidal stomatitis
B37.08 [2000500390]
B37.08 [2000500390]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
6
7
1496
14824
Dislocation of the jaw joint UNS
K07.69 [2000502798]
K07.69 [2000502798]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
6
7
1496
14824
Asthma
J45 [45596282]
J45 [45596282]
5.7e-01
1.0e+00
—
—
—
5.0e-01
5.3e-01
cases:3.70%
controls:2.13%
cases:2.02%
controls:0.72%
—
—
—
—
—
—
cases:1.36%
controls:0.83%
cases:3.79%
controls:2.28%
64
369
1665
16921
35
125
1694
17165
—
—
—
23
140
1667
16693
57
338
1445
14493
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
3.6e-01
8.8e-01
6.9e-02
—
3.1e-01
5.4e-01
3.5e-01
cases:11.74%
controls:8.48%
cases:5.26%
controls:2.24%
cases:0.35%
controls:0.32%
—
—
cases:0.35%
controls:0.25%
cases:3.73%
controls:2.20%
cases:11.52%
controls:8.41%
203
1467
1526
15823
91
388
1638
16902
6
56
1723
17234
—
6
44
1723
17218
63
371
1627
16462
173
1248
1329
13583
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
4.1e-01
5.4e-01
6.6e-01
—
3.7e-01
6.6e-01
5.0e-01
cases:5.73%
controls:3.86%
cases:4.11%
controls:2.43%
cases:0.98%
controls:0.51%
—
—
cases:0.69%
controls:0.48%
cases:4.73%
controls:2.50%
cases:8.52%
controls:5.35%
99
668
1630
16622
71
420
1658
16870
17
88
1712
17202
—
12
83
1717
17179
80
421
1610
16412
128
794
1374
14037
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
3.4e-01
6.2e-01
2.0e-01
—
6.6e-01
8.0e-01
6.9e-01
cases:4.51%
controls:3.26%
cases:3.30%
controls:1.80%
cases:0.35%
controls:0.28%
—
—
cases:0.35%
controls:0.18%
cases:3.37%
controls:1.54%
cases:10.19%
controls:5.38%
78
564
1651
16726
57
312
1672
16978
6
49
1723
17241
—
6
31
1723
17231
57
259
1633
16574
153
798
1349
14033
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
8.2e-01
—
—
—
—
2.1e+00
9.9e-01
cases:0.98%
controls:0.43%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
cases:0.87%
controls:0.32%
17
75
1712
17215
—
—
—
—
9
11
1681
16822
13
48
1489
14783
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
EB1HA [2001301913]
4.0e-01
6.0e-01
5.1e-01
—
9.2e-01
6.3e-01
4.8e-01
cases:9.31%
controls:6.47%
cases:3.12%
controls:1.74%
cases:0.29%
controls:0.17%
—
—
cases:0.35%
controls:0.14%
cases:3.25%
controls:1.76%
cases:11.32%
controls:7.32%
161
1118
1568
16172
54
301
1675
16989
5
30
1724
17260
—
6
24
1723
17238
55
297
1635
16536
170
1085
1332
13746
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
1.1e+00
7.8e-01
—
—
—
1.1e+00
1.0e+00
cases:1.85%
controls:0.65%
cases:0.40%
controls:0.19%
—
—
—
—
—
—
cases:0.53%
controls:0.18%
cases:1.86%
controls:0.67%
32
112
1697
17178
7
32
1722
17258
—
—
—
9
30
1681
16803
28
100
1474
14731
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
10704-5 [3003327]
1.1e+00
6.0e-01
—
—
—
7.7e-01
1.0e+00
cases:1.21%
controls:0.42%
cases:0.35%
controls:0.19%
—
—
—
—
—
—
cases:0.30%
controls:0.14%
cases:1.80%
controls:0.66%
21
72
1708
17218
6
33
1723
17257
—
—
—
5
23
1685
16810
27
98
1475
14733
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
203 [2001600201]
4.7e-01
1.1e+00
—
—
—
4.7e-01
9.6e-01
cases:2.37%
controls:1.49%
cases:0.81%
controls:0.27%
—
—
—
—
—
—
cases:0.53%
controls:0.33%
cases:2.86%
controls:1.11%
41
258
1688
17032
14
46
1715
17244
—
—
—
9
56
1681
16777
43
165
1459
14666
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
2.7e-01
7.5e-01
8.2e-01
—
—
6.8e-01
6.5e-01
cases:2.14%
controls:1.64%
cases:1.85%
controls:0.88%
cases:0.29%
controls:0.13%
—
—
—
—
cases:1.83%
controls:0.94%
cases:6.13%
controls:3.30%
37
284
1692
17006
32
153
1697
17137
5
22
1724
17268
—
—
31
158
1659
16675
92
489
1410
14342
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
8.2e-01
5.9e-01
—
—
1.3e+00
1.1e+00
9.7e-01
cases:1.10%
controls:0.49%
cases:0.40%
controls:0.23%
—
—
—
—
cases:0.29%
controls:0.08%
cases:0.77%
controls:0.26%
cases:1.26%
controls:0.49%
19
84
1710
17206
7
39
1722
17251
—
—
5
13
1724
17249
13
43
1677
16790
19
72
1483
14759
Benign neoplasm: Rectum
D12.8 [45595734]
D12.8 [45595734]
1.1e+00
—
—
—
—
—
1.0e+00
cases:0.81%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.37%
14
48
1715
17242
—
—
—
—
—
15
55
1487
14776
Other specified intervertebral disc disorders
M51.8 [45606244]
M51.8 [45606244]
2.1e+00
—
—
—
—
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
1722
17281
—
—
—
—
—
—
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
5.5e-01
5.6e-01
6.6e-01
—
4.4e-01
5.4e-01
4.1e-01
cases:5.61%
controls:3.33%
cases:3.30%
controls:1.91%
cases:0.64%
controls:0.33%
—
—
cases:0.52%
controls:0.34%
cases:3.43%
controls:2.04%
cases:8.26%
controls:5.62%
97
576
1632
16714
57
331
1672
16959
11
57
1718
17233
—
9
58
1720
17204
58
343
1632
16490
124
833
1378
13998
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
5.2e-01
8.3e-01
1.4e+00
—
—
4.9e-01
7.0e-01
cases:3.24%
controls:1.96%
cases:1.33%
controls:0.58%
cases:0.29%
controls:0.07%
—
—
—
—
cases:0.83%
controls:0.51%
cases:3.86%
controls:1.96%
56
339
1673
16951
23
101
1706
17189
5
12
1724
17278
—
—
14
86
1676
16747
58
290
1444
14541
Acoustic channel extensive MRI examination with high intensity magnet
DE2CG [2001301607]
DE2CG [2001301607]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.06%
—
—
—
—
—
—
7
9
1495
14822
Acute maxillary sinusitis
J01.0 [45601112]
J01.0 [45601112]
5.9e-01
9.6e-01
8.4e-01
1.0e+50
1.1e+00
5.4e-01
4.8e-01
cases:5.90%
controls:3.34%
cases:3.18%
controls:1.24%
cases:0.35%
controls:0.15%
cases:0.29%
controls:0.00%
cases:0.46%
controls:0.15%
cases:2.07%
controls:1.22%
cases:7.12%
controls:4.52%
102
578
1627
16712
55
214
1674
17076
6
26
1723
17264
5
0
1724
17290
8
26
1721
17236
35
205
1655
16628
107
670
1395
14161
Generalized anxiety disorder
F41.1 [45571764]
F41.1 [45571764]
9.2e-01
5.7e-01
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:1.04%
controls:0.42%
cases:0.35%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.71%
controls:0.24%
cases:1.86%
controls:0.62%
18
72
1711
17218
6
34
1723
17256
—
—
0
7
1729
17255
12
40
1678
16793
28
92
1474
14739
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
2.7e-01
9.7e-01
5.7e-01
—
3.4e-01
3.8e-01
4.1e-01
cases:26.60%
controls:21.71%
cases:15.21%
controls:6.38%
cases:1.21%
controls:0.69%
—
—
cases:0.81%
controls:0.58%
cases:8.76%
controls:6.13%
cases:27.16%
controls:19.80%
460
3754
1269
13536
263
1103
1466
16187
21
119
1708
17171
—
14
100
1715
17162
148
1032
1542
15801
408
2936
1094
11895
Back syndrome with radiating pain
L86 [2002000705]
L86 [2002000705]
1.1e+00
8.8e-01
—
—
—
1.1e+00
9.7e-01
cases:1.04%
controls:0.36%
cases:0.35%
controls:0.14%
—
—
—
—
—
—
cases:0.30%
controls:0.10%
cases:1.40%
controls:0.53%
18
63
1711
17227
6
25
1723
17265
—
—
—
5
17
1685
16816
21
79
1481
14752
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
9.0e-01
1.2e+00
—
—
-1.0e+50
5.7e-01
1.1e+00
cases:1.68%
controls:0.69%
cases:0.69%
controls:0.21%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.36%
controls:0.20%
cases:2.26%
controls:0.75%
29
119
1700
17171
12
37
1717
17253
—
—
0
10
1729
17252
6
34
1684
16799
34
111
1468
14720
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
3.9e-01
6.6e-01
—
—
—
1.1e+00
9.1e-01
cases:2.20%
controls:1.50%
cases:0.81%
controls:0.42%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.80%
controls:1.15%
38
259
1691
17031
14
73
1715
17217
—
—
—
20
66
1670
16767
42
170
1460
14661
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
3.9e-01
6.6e-01
—
—
—
1.1e+00
9.1e-01
cases:2.20%
controls:1.50%
cases:0.81%
controls:0.42%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.80%
controls:1.15%
38
259
1691
17031
14
73
1715
17217
—
—
—
20
66
1670
16767
42
170
1460
14661
Congenital non-neoplastic naevus
Q82.58 [2000503507]
Q82.58 [2000503507]
2.0e+00
—
—
—
—
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1723
17282
—
—
—
—
—
—
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
5.1e-01
4.7e-01
7.7e-01
—
5.8e-01
6.5e-01
8.6e-01
cases:3.30%
controls:2.01%
cases:1.85%
controls:1.17%
cases:0.69%
controls:0.32%
—
—
cases:0.58%
controls:0.32%
cases:2.19%
controls:1.15%
cases:4.59%
controls:2.00%
57
348
1672
16942
32
202
1697
17088
12
56
1717
17234
—
10
56
1719
17206
37
194
1653
16639
69
297
1433
14534
golimumab; parenteral
L04AB06 [21603913]
L04AB06 [21603913]
1.9e+00
—
—
—
—
—
2.0e+00
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.08%
6
9
1723
17281
—
—
—
—
—
9
12
1493
14819
Cluster headache syndrome
G44.0 [45533141]
G44.0 [45533141]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.08%
—
—
—
—
—
—
9
12
1493
14819
Bilateral foot X-ray examination
NH3DA [2001308279]
NH3DA [2001308279]
1.0e+00
—
—
—
—
—
2.0e+00
cases:0.35%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.08%
6
22
1723
17268
—
—
—
—
—
9
12
1493
14819
Dyspareunia
N94.1 [45534149]
N94.1 [45534149]
—
—
—
—
—
-1.0e+50
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.40%
controls:0.05%
—
—
—
—
—
0
6
1690
16827
6
8
1496
14823
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
NGE35 [2001308121]
NGE35 [2001308121]
9.2e-01
-1.0e+50
—
—
—
—
2.0e+00
cases:0.29%
controls:0.12%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
5
20
1724
17270
0
6
1729
17284
—
—
—
—
6
8
1496
14823
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
6.5e-01
3.0e-01
3.6e-01
—
6.3e-01
7.1e-01
6.5e-01
cases:6.48%
controls:3.49%
cases:2.31%
controls:1.72%
cases:0.87%
controls:0.61%
—
—
cases:1.10%
controls:0.59%
cases:3.49%
controls:1.75%
cases:7.26%
controls:3.94%
112
604
1617
16686
40
298
1689
16992
15
105
1714
17185
—
19
102
1710
17160
59
295
1631
16538
109
584
1393
14247
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
1.0e+00
1.1e+00
—
—
—
9.1e-01
9.5e-01
cases:1.33%
controls:0.47%
cases:0.52%
controls:0.17%
—
—
—
—
—
—
cases:0.30%
controls:0.12%
cases:1.73%
controls:0.67%
23
82
1706
17208
9
30
1720
17260
—
—
—
5
20
1685
16813
26
100
1476
14731
Electrocardiogram with exercise test
46136006 [4261794]
46136006 [4261794]
6.4e-01
1.7e-02
-1.0e+50
—
—
1.3e+00
4.7e-01
cases:2.08%
controls:1.10%
cases:0.35%
controls:0.34%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.89%
controls:0.23%
cases:1.46%
controls:0.92%
36
191
1693
17099
6
59
1723
17231
0
7
1729
17283
—
—
15
39
1675
16794
22
137
1480
14694
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
4.3e-01
4.6e-01
5.0e-01
—
-1.5e-01
6.3e-01
4.7e-01
cases:20.82%
controls:14.55%
cases:9.49%
controls:6.22%
cases:1.27%
controls:0.78%
—
—
cases:0.69%
controls:0.81%
cases:10.00%
controls:5.61%
cases:25.50%
controls:17.63%
360
2515
1369
14775
164
1075
1565
16215
22
134
1707
17156
—
12
139
1717
17123
169
944
1521
15889
383
2614
1119
12217
Feeling depressed
P03 [2002000800]
P03 [2002000800]
7.2e-01
7.8e-01
1.6e+00
—
—
1.3e+00
3.9e-01
cases:2.08%
controls:1.02%
cases:0.93%
controls:0.43%
cases:0.35%
controls:0.07%
—
—
—
—
cases:1.01%
controls:0.29%
cases:1.80%
controls:1.22%
36
177
1693
17113
16
74
1713
17216
6
12
1723
17278
—
—
17
48
1673
16785
27
181
1475
14650
Subjective visual disturbances
H53.1 [45557467]
H53.1 [45557467]
1.0e+00
5.8e-01
—
—
—
6.4e-01
9.5e-01
cases:1.21%
controls:0.43%
cases:0.29%
controls:0.16%
—
—
—
—
—
—
cases:0.47%
controls:0.25%
cases:2.13%
controls:0.84%
21
75
1708
17215
5
28
1724
17262
—
—
—
8
42
1682
16791
32
124
1470
14707
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
4.2e-01
4.3e-01
8.5e-01
—
2.6e-01
4.8e-01
6.5e-01
cases:11.28%
controls:7.69%
cases:4.57%
controls:3.03%
cases:0.98%
controls:0.42%
—
—
cases:0.58%
controls:0.45%
cases:4.44%
controls:2.80%
cases:15.98%
controls:9.02%
195
1330
1534
15960
79
524
1650
16766
17
73
1712
17217
—
10
77
1719
17185
75
471
1615
16362
240
1338
1262
13493
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
3.3e-01
6.2e-01
1.8e-01
—
6.6e-01
7.1e-01
6.5e-01
cases:4.63%
controls:3.36%
cases:3.47%
controls:1.90%
cases:0.35%
controls:0.29%
—
—
cases:0.35%
controls:0.18%
cases:3.37%
controls:1.69%
cases:10.25%
controls:5.63%
80
581
1649
16709
60
329
1669
16961
6
50
1723
17240
—
6
31
1723
17231
57
284
1633
16549
154
835
1348
13996
Low back symptom/complaint
L03 [2002000628]
L03 [2002000628]
6.0e-01
8.3e-01
—
—
—
5.8e-01
5.5e-01
cases:5.21%
controls:2.94%
cases:2.66%
controls:1.18%
—
—
—
—
—
—
cases:2.01%
controls:1.13%
cases:8.06%
controls:4.81%
90
508
1639
16782
46
204
1683
17086
—
—
—
34
191
1656
16642
121
713
1381
14118
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
4.3e-01
5.0e-01
-1.0e+50
—
—
9.1e-01
6.2e-01
cases:8.62%
controls:5.80%
cases:2.72%
controls:1.66%
cases:0.00%
controls:0.23%
—
—
—
—
cases:3.08%
controls:1.26%
cases:6.92%
controls:3.84%
149
1002
1580
16288
47
287
1682
17003
0
39
1729
17251
—
—
52
212
1638
16621
104
570
1398
14261
organo-heparinoid; ointment
C05BA01 [21601636]
C05BA01 [21601636]
1.1e+00
—
—
—
—
—
1.9e+00
cases:0.29%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
5
17
1724
17273
—
—
—
—
—
7
10
1495
14821
Cerebrospinal fluid IgG ratio and IgG index
1324000 [4027681]
1324000 [4027681]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
—
—
—
—
—
—
7
10
1495
14821
Appearance of Synovial fluid
29605-3 [3024263]
29605-3 [3024263]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
—
—
—
—
—
—
7
10
1495
14821
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
1.0e+00
—
—
—
—
1.9e+00
1.0e+00
cases:0.52%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.08%
cases:0.80%
controls:0.29%
9
32
1720
17258
—
—
—
—
9
13
1681
16820
12
43
1490
14788
Functional dyspepsia
K30 [45591584]
K30 [45591584]
4.8e-01
9.7e-01
—
—
—
5.3e-01
9.5e-01
cases:1.79%
controls:1.12%
cases:0.93%
controls:0.35%
—
—
—
—
—
—
cases:0.59%
controls:0.35%
cases:3.53%
controls:1.40%
31
194
1698
17096
16
61
1713
17229
—
—
—
10
59
1680
16774
53
207
1449
14624
Other and unspecified ovarian cysts
N83.2 [45539066]
N83.2 [45539066]
7.8e-01
4.9e-01
—
—
—
1.1e+00
6.0e-01
cases:2.02%
controls:0.94%
cases:0.52%
controls:0.32%
—
—
—
—
—
—
cases:0.83%
controls:0.27%
cases:1.66%
controls:0.92%
35
162
1694
17128
9
55
1720
17235
—
—
—
14
45
1676
16788
25
137
1477
14694
Endoscopic ethmoidectomy
DNB20 [2001301791]
DNB20 [2001301791]
8.3e-01
—
—
—
—
—
1.9e+00
cases:0.46%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.15%
8
35
1721
17255
—
—
—
—
—
15
22
1487
14809
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
-4.2e-02
-6.1e-02
—
—
-1.0e+50
1.2e+00
7.0e-01
cases:1.21%
controls:1.27%
cases:0.46%
controls:0.49%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.89%
controls:0.27%
cases:1.86%
controls:0.93%
21
219
1708
17071
8
85
1721
17205
—
—
0
5
1729
17257
15
45
1675
16788
28
138
1474
14693
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
1.2e+00
—
—
—
—
1.9e+00
8.8e-01
cases:0.52%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
cases:0.53%
controls:0.22%
9
27
1720
17263
—
—
—
—
8
12
1682
16821
8
33
1494
14798
Prick test
37968009 [4242723]
37968009 [4242723]
7.7e-01
6.9e-01
—
1.0e+50
—
1.1e+00
1.1e+00
cases:1.50%
controls:0.70%
cases:0.29%
controls:0.14%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.59%
controls:0.20%
cases:1.33%
controls:0.44%
26
121
1703
17169
5
25
1724
17265
—
5
0
1724
17290
—
10
34
1680
16799
20
65
1482
14766
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
-1.9e-02
1.6e-01
—
—
—
1.0e+00
8.7e-01
cases:2.83%
controls:2.89%
cases:0.81%
controls:0.69%
—
—
—
—
—
—
cases:1.42%
controls:0.52%
cases:3.66%
controls:1.56%
49
499
1680
16791
14
120
1715
17170
—
—
—
24
87
1666
16746
55
232
1447
14599
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
LC2AE [2001306543]
9.2e-01
2.7e-01
—
—
-1.0e+50
8.3e-01
9.5e-01
cases:1.91%
controls:0.77%
cases:0.46%
controls:0.35%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.47%
controls:0.21%
cases:1.40%
controls:0.55%
33
133
1696
17157
8
61
1721
17229
—
—
0
7
1729
17255
8
35
1682
16798
21
81
1481
14750
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
6.5e-01
4.4e-01
5.9e-01
—
6.7e-01
6.8e-01
5.3e-01
cases:8.85%
controls:4.81%
cases:3.30%
controls:2.14%
cases:0.40%
controls:0.23%
—
—
cases:0.40%
controls:0.21%
cases:4.56%
controls:2.36%
cases:13.91%
controls:8.65%
153
832
1576
16458
57
370
1672
16920
7
39
1722
17251
—
7
36
1722
17226
77
397
1613
16436
209
1283
1293
13548
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
5.1e-01
3.3e-01
4.3e-01
—
3.3e-01
6.9e-01
6.7e-01
cases:11.68%
controls:7.39%
cases:3.59%
controls:2.61%
cases:0.81%
controls:0.53%
—
—
cases:0.64%
controls:0.46%
cases:4.56%
controls:2.34%
cases:12.12%
controls:6.57%
202
1277
1527
16013
62
452
1667
16838
14
91
1715
17199
—
11
79
1718
17183
77
394
1613
16439
182
975
1320
13856
Migraine, unspecified
G43.9 [45595943]
G43.9 [45595943]
9.1e-01
1.1e+00
—
1.0e+50
—
1.2e+00
9.6e-01
cases:1.50%
controls:0.61%
cases:0.46%
controls:0.15%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.65%
controls:0.20%
cases:1.86%
controls:0.72%
26
106
1703
17184
8
26
1721
17264
—
5
0
1724
17290
—
11
33
1679
16800
28
107
1474
14724
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
7.1e-01
1.2e+00
—
—
—
8.6e-01
6.6e-01
cases:1.79%
controls:0.89%
cases:1.04%
controls:0.33%
—
—
—
—
—
—
cases:1.01%
controls:0.43%
cases:1.66%
controls:0.87%
31
154
1698
17136
18
57
1711
17233
—
—
—
17
72
1673
16761
25
129
1477
14702
Palpitations
R00.2 [45558446]
R00.2 [45558446]
1.1e+00
8.9e-01
—
—
—
3.9e-01
8.0e-01
cases:1.85%
controls:0.65%
cases:0.58%
controls:0.24%
—
—
—
—
—
—
cases:0.47%
controls:0.32%
cases:2.06%
controls:0.94%
32
112
1697
17178
10
41
1719
17249
—
—
—
8
54
1682
16779
31
139
1471
14692
mupirocin; nasal
R01AX06 [21603201]
R01AX06 [21603201]
1.0e+00
6.0e-01
—
—
—
1.1e+00
8.5e-01
cases:1.33%
controls:0.49%
cases:0.46%
controls:0.25%
—
—
—
—
—
—
cases:0.65%
controls:0.21%
cases:1.66%
controls:0.72%
23
84
1706
17206
8
44
1721
17246
—
—
—
11
36
1679
16797
25
107
1477
14724
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.1e-01
5.4e-01
5.4e-01
1.7e+00
5.2e-01
5.1e-01
5.0e-01
cases:11.45%
controls:8.65%
cases:8.79%
controls:5.34%
cases:1.68%
controls:0.98%
cases:0.40%
controls:0.08%
cases:1.68%
controls:1.01%
cases:9.05%
controls:5.66%
cases:20.11%
controls:13.21%
198
1496
1531
15794
152
923
1577
16367
29
170
1700
17120
7
13
1722
17277
29
174
1700
17088
153
953
1537
15880
302
1959
1200
12872
Lichen rubs planus in the mouth
K13.74 [2000502892]
K13.74 [2000502892]
1.9e+00
—
—
—
—
—
6.8e-01
cases:0.40%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.17%
7
11
1722
17279
—
—
—
—
—
5
25
1497
14806
Cellulitis of external ear
H60.1 [45547946]
H60.1 [45547946]
1.9e+00
—
—
—
—
—
-1.0e+50
cases:0.40%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
7
11
1722
17279
—
—
—
—
—
0
14
1502
14817
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
M32.9 [45553167]
1.9e+00
—
—
—
—
—
1.5e+00
cases:0.40%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.07%
7
11
1722
17279
—
—
—
—
—
5
11
1497
14820
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
4.3e-01
5.7e-01
5.4e-01
—
1.1e-01
3.5e-01
5.0e-01
cases:19.90%
controls:13.85%
cases:12.09%
controls:7.22%
cases:1.91%
controls:1.12%
—
—
cases:1.39%
controls:1.24%
cases:9.82%
controls:7.13%
cases:24.17%
controls:16.20%
344
2395
1385
14895
209
1248
1520
16042
33
193
1696
17097
—
24
214
1705
17048
166
1201
1524
15632
363
2402
1139
12429
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
4.0e-01
7.2e-01
—
—
—
9.9e-01
8.6e-01
cases:2.60%
controls:1.76%
cases:0.98%
controls:0.48%
—
—
—
—
—
—
cases:1.07%
controls:0.40%
cases:3.73%
controls:1.61%
45
305
1684
16985
17
83
1712
17207
—
—
—
18
67
1672
16766
56
239
1446
14592
Sialoadenitis
K11.2 [45586705]
K11.2 [45586705]
9.4e-01
—
—
—
—
1.8e+00
4.1e-01
cases:0.75%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.07%
cases:0.47%
controls:0.31%
13
51
1716
17239
—
—
—
—
7
11
1683
16822
7
46
1495
14785
Paralysis of vocal cords and larynx
J38.0 [45543265]
J38.0 [45543265]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
—
—
—
—
—
—
7
11
1495
14820
Vertigo/dizziness
N17 [2002000728]
N17 [2002000728]
8.3e-01
8.8e-01
—
—
—
1.0e+00
1.0e+00
cases:1.85%
controls:0.82%
cases:0.69%
controls:0.29%
—
—
—
—
—
—
cases:0.83%
controls:0.30%
cases:3.20%
controls:1.19%
32
141
1697
17149
12
50
1717
17240
—
—
—
14
51
1676
16782
48
176
1454
14655
Tinnitus
H93.1 [45543152]
H93.1 [45543152]
8.9e-01
9.2e-01
—
—
-1.0e+50
1.2e+00
9.5e-01
cases:1.33%
controls:0.55%
cases:0.46%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.65%
controls:0.20%
cases:2.06%
controls:0.81%
23
95
1706
17195
8
32
1721
17258
—
—
0
6
1729
17256
11
33
1679
16800
31
120
1471
14711
Pain, unspecified
R52.9 [45544151]
R52.9 [45544151]
8.7e-01
8.8e-01
-1.0e+50
—
—
8.1e-01
9.7e-01
cases:1.62%
controls:0.69%
cases:0.64%
controls:0.27%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.65%
controls:0.29%
cases:3.06%
controls:1.18%
28
119
1701
17171
11
46
1718
17244
0
5
1729
17285
—
—
11
49
1679
16784
46
175
1456
14656
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
8.1e-01
9.9e-01
—
—
—
1.1e+00
1.0e+00
cases:1.45%
controls:0.65%
cases:0.64%
controls:0.24%
—
—
—
—
—
—
cases:0.65%
controls:0.23%
cases:1.80%
controls:0.65%
25
112
1704
17178
11
41
1718
17249
—
—
—
11
38
1679
16795
27
97
1475
14734
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.1e-01
5.4e-01
5.5e-01
1.7e+00
5.5e-01
4.9e-01
5.0e-01
cases:11.39%
controls:8.62%
cases:8.73%
controls:5.30%
cases:1.68%
controls:0.98%
cases:0.40%
controls:0.08%
cases:1.74%
controls:1.01%
cases:8.88%
controls:5.66%
cases:19.97%
controls:13.14%
197
1491
1532
15799
151
917
1578
16373
29
169
1700
17121
7
13
1722
17277
30
174
1699
17088
150
952
1540
15881
300
1949
1202
12882
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
2.8e-01
5.5e-01
5.9e-01
1.7e+00
4.9e-01
5.3e-01
4.7e-01
cases:10.47%
controls:8.12%
cases:8.27%
controls:4.95%
cases:1.62%
controls:0.90%
cases:0.35%
controls:0.06%
cases:1.56%
controls:0.96%
cases:8.40%
controls:5.11%
cases:17.91%
controls:12.01%
181
1404
1548
15886
143
855
1586
16435
28
156
1701
17134
6
11
1723
17279
27
166
1702
17096
142
861
1548
15972
269
1781
1233
13050
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
7.2e-01
3.6e-01
—
—
—
9.8e-01
1.1e+00
cases:1.62%
controls:0.79%
cases:0.46%
controls:0.32%
—
—
—
—
—
—
cases:0.71%
controls:0.27%
cases:1.73%
controls:0.58%
28
137
1701
17153
8
56
1721
17234
—
—
—
12
45
1678
16788
26
86
1476
14745
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
7.7e-01
4.5e-01
—
—
—
5.6e-01
1.1e+00
cases:1.68%
controls:0.79%
cases:0.46%
controls:0.29%
—
—
—
—
—
—
cases:0.41%
controls:0.24%
cases:1.73%
controls:0.61%
29
136
1700
17154
8
51
1721
17239
—
—
—
7
40
1683
16793
26
90
1476
14741
Depressive disorder
P76 [2002000870]
P76 [2002000870]
7.2e-01
8.8e-01
—
—
—
8.0e-01
1.1e+00
cases:1.56%
controls:0.76%
cases:0.69%
controls:0.29%
—
—
—
—
—
—
cases:0.59%
controls:0.27%
cases:2.13%
controls:0.72%
27
132
1702
17158
12
50
1717
17240
—
—
—
10
45
1680
16788
32
107
1470
14724
budesonide; nasal
R01AD05 [21605047]
R01AD05 [21605047]
7.7e-01
1.8e+00
—
—
—
—
1.4e+00
cases:0.46%
controls:0.21%
cases:0.46%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.11%
8
37
1721
17253
8
13
1721
17277
—
—
—
—
7
17
1495
14814
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
4.5e-01
8.2e-01
—
—
—
5.7e-01
5.4e-01
cases:4.97%
controls:3.23%
cases:2.43%
controls:1.09%
—
—
—
—
—
—
cases:1.89%
controls:1.08%
cases:6.52%
controls:3.92%
86
559
1643
16731
42
188
1687
17102
—
—
—
32
181
1658
16652
98
582
1404
14249
Human epididymis protein 4 [Moles/volume] in Serum or Plasma
55180-4 [40758310]
55180-4 [40758310]
9.6e-01
—
—
—
—
1.8e+00
3.1e-01
cases:0.81%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.09%
cases:0.47%
controls:0.34%
14
54
1715
17236
—
—
—
—
9
15
1681
16818
7
51
1495
14780
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
3.7e-01
9.4e-01
—
—
—
2.1e-01
4.7e-01
cases:6.30%
controls:4.42%
cases:2.08%
controls:0.82%
—
—
—
—
—
—
cases:1.01%
controls:0.81%
cases:4.53%
controls:2.87%
109
765
1620
16525
36
142
1693
17148
—
—
—
17
137
1673
16696
68
425
1434
14406
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.6e-01
6.4e-01
5.6e-01
—
8.4e-01
5.5e-01
6.1e-01
cases:7.98%
controls:6.27%
cases:6.02%
controls:3.28%
cases:0.98%
controls:0.57%
—
—
cases:1.04%
controls:0.45%
cases:6.09%
controls:3.62%
cases:16.64%
controls:9.82%
138
1084
1591
16206
104
567
1625
16723
17
98
1712
17192
—
18
78
1711
17184
103
609
1587
16224
250
1457
1252
13374
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
3.1e-01
3.2e-01
—
—
7.4e-01
8.1e-01
6.7e-01
cases:9.37%
controls:7.07%
cases:3.82%
controls:2.79%
—
—
—
—
cases:0.52%
controls:0.25%
cases:5.27%
controls:2.42%
cases:14.91%
controls:8.20%
162
1223
1567
16067
66
482
1663
16808
—
—
9
43
1720
17219
89
407
1601
16426
224
1216
1278
13615
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
952
6793
1.89
36.24
2.4
2.0
98.50
97.34
pmol/l
0.31
525
3486
1397
11577
2.08
31.19
5.4
4.4
10.63
12.23
mm/h
5.10
1325
10847
662
4533
1.75
26.05
2.4
2.0
145.61
215.94
u/l
1.93
634
4276
348
1978
1.95
24.94
2.3
2.4
82.13
130.50
ug/g
4.46
277
1577
1413
12162
1.89
22.62
5.3
4.6
14.81
14.79
pmol/l
0.12
1324
11208
934
7286
1.61
20.60
3.7
3.0
103.51
124.79
ug/l
3.74
882
6829
1579
14268
2.23
19.97
6.7
5.5
1.81
1.91
mu/l
3.91
1500
13233
977
7742
1.60
19.88
6.6
7.3
1.22
1.21
mmol/l
0.51
867
6721
531
3627
1.67
19.88
1.4
1.3
1.21
1.62
u/ml
0.57
150
1003
603
4255
1.64
19.87
1.8
1.6
19.54
20.78
nmol/l
1.34
521
3536
368
2292
1.77
19.20
1.8
1.7
1111.22
1183.19
nmol/l
0.89
293
1727
1100
9020
1.60
18.94
9.4
9.9
3.84
4.02
e9/l
2.09
967
7843
744
5610
1.57
18.13
3.8
3.4
26.50
127.93
ng/l
0.67
489
3867
1376
12008
1.71
17.75
8.6
8.4
75.31
79.23
u/l
3.75
1322
11401
655
4859
1.56
16.79
2.7
2.6
60.14
78.09
u/l
0.55
600
4513
461
3156
1.63
16.59
1.6
1.5
2.48
2.41
g/l
0.16
275
1956
875
6935
1.53
16.48
6.4
6.6
1.22
1.21
mmol/l
0.53
821
6426
1172
9902
1.57
16.45
5.8
4.5
26.67
1734.76
e6/l
—
6
137
548
3923
1.58
16.31
2.5
2.2
2.73
2.79
mg/l
0.34
476
3385
909
7286
1.52
16.08
2.7
2.4
80.39
78.72
nmol/l
1.03
827
6614
197
1085
1.92
15.06
1.3
1.3
215.49
202.95
u/ml
0.07
183
999
855
6826
1.50
15.01
14.0
13.2
1.23
1.21
inr
0.49
716
5592
1198
10294
1.53
14.48
3.4
3.3
44.58
48.91
u/l
0.77
1128
9697
1617
15029
2.17
14.48
18.1
15.1
21.27
23.79
mg/l
2.56
1378
12250
448
3136
1.58
14.37
1.4
1.3
27.70
34.75
iu/ml
0.70
137
974
422
2921
1.59
14.18
1.4
1.3
8.72
12.25
u/ml
0.56
160
1136
857
6901
1.48
14.08
4.9
5.2
36.56
35.73
g/l
5.10
815
6512
1651
15511
2.43
13.78
20.1
17.5
139.93
139.74
mmol/l
2.98
1621
15220
1653
15540
2.45
13.74
20.3
17.7
3.96
3.96
mmol/l
0.30
1621
15216
1058
8909
1.48
13.69
5.1
5.0
6.40
6.66
mmol/l
5.06
1018
8443
439
3091
1.56
13.63
2.9
3.0
2.45
2.45
mmol/l
0.59
407
2795
1593
14787
1.98
13.35
5.9
5.2
5.82
5.91
mmol/l
2.40
1488
13630
210
1237
1.79
12.92
1.6
1.5
—
—
—
0
0
109
515
2.19
12.64
1.8
1.6
—
—
—
0
0
124
621
2.07
12.38
1.3
1.2
0.30
1.06
u/ml
0.91
14
42
1564
14487
1.83
12.38
6.9
6.3
38.32
39.14
mmol/mol
4.31
1479
13570
703
5545
1.45
12.29
3.4
3.7
2.36
2.36
mmol/l
0.02
638
5068
321
2147
1.61
12.27
1.9
2.1
29.35
29.51
s
0.15
314
2084
373
2612
1.55
11.63
1.8
1.5
—
—
—
0
0
1633
15388
2.10
11.60
6.7
5.9
2.73
2.76
mmol/l
0.74
1550
14353
979
8267
1.42
11.47
6.1
6.9
10.32
11.25
umol/l
3.43
933
7905
975
8271
1.41
10.86
4.5
3.8
0.00
5.44
estimate
1.83
167
1769
966
8194
1.41
10.69
4.5
3.8
0.00
0.00
estimate
0.50
161
1723
65
265
2.51
10.58
1.5
1.5
15.58
66.86
e6/l
0.87
50
195
622
4899
1.42
10.52
4.2
3.2
23.71
80.80
e6/l
2.48
494
3672
577
4487
1.43
10.47
3.1
3.0
685.91
1063.63
ng/l
4.84
499
3831
65
268
2.48
10.33
1.5
1.5
1037.11
1322.44
e6/l
0.11
55
209
1604
15107
1.85
10.13
5.7
5.1
1.51
1.51
mmol/l
0.01
1514
14048
1673
16010
2.39
9.84
14.2
12.2
24.73
25.73
u/l
2.30
1637
15589
975
8355
1.38
9.73
4.6
3.9
0.02
0.01
estimate
0.18
161
1655
381
2771
1.48
9.73
5.1
3.5
183.16
459.79
ng/l
2.68
284
2098
426
3167
1.46
9.72
1.8
1.7
12948117.17
32497582.94
pmol/l
0.64
363
2631
1608
15189
1.84
9.59
5.9
5.2
4.69
4.74
mmol/l
1.22
1525
14223
364
2632
1.49
9.55
3.7
2.8
0.76
1.12
e6/l
2.52
213
1356
220
1429
1.62
9.35
2.1
2.2
360.66
376.89
nmol/l
0.58
209
1320
1677
16105
2.37
9.06
23.3
19.7
74.59
74.80
umol/l
0.12
1661
15925
538
4229
1.40
8.87
4.1
3.1
0.29
0.42
e6/l
0.96
403
3028
160
971
1.71
8.83
2.6
2.3
12.76
12.98
nmol/l
0.12
145
877
1541
14441
1.62
8.79
4.8
4.3
1.25
1.29
mmol/l
1.43
1443
13315
1055
9241
1.36
8.70
3.1
2.9
—
—
—
0
0
158
960
1.71
8.68
1.4
1.3
31.34
56.97
au/ml
—
9
68
19
40
4.79
8.59
1.1
1.1
691.73
547.53
ng/l
0.85
11
15
108
587
1.90
8.59
1.6
1.6
19.29
13.43
u/ml
0.35
21
130
19
41
4.67
8.35
1.1
1.0
321.73
256.13
ng/l
0.38
11
16
19
41
4.67
8.35
1.1
1.1
35.25
34.89
ng/l
—
10
16
438
3354
1.41
8.33
3.1
2.6
4.90
6.35
e6/l
1.50
403
3044
168
1051
1.66
8.28
2.6
2.4
14.49
22.03
au/ml
1.22
19
113
257
1778
1.52
8.27
6.8
6.4
—
—
—
0
0
181
1157
1.63
8.19
2.5
2.2
6.21
7.76
ug/l
0.80
159
1046
441
3410
1.39
7.86
1.9
1.7
1.06
1.23
mg/l
0.53
349
2657
1562
14750
1.61
7.85
17.1
14.8
81.25
80.79
ml/min/173m2
0.43
1466
13648
190
1245
1.59
7.77
2.1
2.4
0.48
0.55
e6/l
0.14
180
1183
75
373
2.06
7.71
1.3
1.2
1.12
5.10
u/ml
—
6
22
496
3923
1.37
7.67
4.4
4.0
91.60
92.10
%
0.17
489
3841
24
67
3.62
7.58
1.4
1.2
0.78
0.54
ratio
0.33
15
36
114
658
1.78
7.51
1.9
1.8
6.15
8.76
iu/ml
0.43
27
150
25
74
3.41
7.26
1.1
1.1
1.10
1.17
u/l
—
9
41
86
460
1.92
7.22
1.3
1.2
3.93
9.75
u/ml
0.35
12
42
86
462
1.91
7.13
1.3
1.3
3.65
10.63
u/ml
1.07
15
72
1695
16455
2.53
7.12
27.8
23.2
251.12
255.10
e9/l
1.92
1666
16126
34
123
2.80
7.08
1.2
1.1
—
—
—
0
0
1695
16458
2.52
7.06
27.7
23.1
91.20
91.22
fl
0.05
1676
16294
73
372
2.00
7.05
1.2
1.2
60.83
58.66
u/ml
—
7
38
510
4098
1.35
7.01
2.8
2.7
333.17
334.20
umol/l
0.09
455
3653
1695
16461
2.51
7.00
28.3
23.7
40.46
40.25
%
1.09
1676
16290
1695
16461
2.51
7.00
27.8
23.2
4.49
4.47
e12/l
0.65
1664
16073
34
124
2.78
6.98
1.2
1.1
—
—
—
0
0
1695
16463
2.50
6.96
27.8
23.2
6.47
6.67
e9/l
2.80
1663
16072
1695
16465
2.50
6.92
28.0
23.3
135.17
134.73
g/l
0.72
1677
16304
89
490
1.86
6.85
1.4
1.2
44.84
40.93
u/ml
—
8
26
342
2601
1.39
6.60
3.1
3.6
0.82
0.82
mmol/l
0.20
319
2457
45
194
2.35
6.60
1.5
1.3
—
—
—
0
0
34
128
2.69
6.59
1.2
1.1
—
—
—
0
0
34
128
2.69
6.59
1.2
1.1
—
—
—
0
0
320
2413
1.40
6.49
3.9
2.9
2.94
2.82
e6/l
0.08
168
1131
77
413
1.90
6.44
3.4
3.6
2.71
2.39
index
0.17
38
211
478
3853
1.33
6.33
2.2
2.4
—
—
—
0
0
28
97
2.92
6.33
1.2
1.1
44.18
39.39
mg/l
0.11
22
78
34
135
2.55
5.96
1.2
1.1
—
—
—
0
0
338
2611
1.37
5.88
2.5
2.6
13.64
13.17
umol/l
0.65
321
2433
785
6823
1.28
5.76
2.0
1.9
1.33
1.36
mmol/l
0.54
670
5746
450
3658
1.31
5.50
5.0
3.9
1.02
1.43
kg/l
0.50
286
2417
835
7345
1.26
5.44
2.6
2.8
—
—
estimate
—
0
0
36
154
2.37
5.42
1.3
1.1
—
—
—
0
0
122
789
1.59
5.31
1.1
1.0
—
—
—
0
0
312
2419
1.35
5.27
2.5
2.6
2.38
2.33
g/l
0.95
288
2230
231
1711
1.40
5.16
1.6
1.8
1.39
1.45
%
0.78
201
1500
119
771
1.58
5.15
1.4
1.4
31.19
31.66
iu/l
0.05
99
673
171
1200
1.47
5.11
3.0
3.7
75.03
84.17
ng/l
1.22
149
1046
179
1269
1.46
5.08
2.7
2.6
67.42
67.02
ml/min/173m2
0.05
73
514
64
351
1.86
5.07
1.3
1.4
10.28
11.46
u/l
0.28
53
285
28
110
2.57
5.05
1.1
1.1
—
—
—
0
0
42
199
2.14
5.00
1.2
1.3
29.10
48.79
u/ml
—
5
10
132
891
1.52
4.78
1.6
1.7
—
—
—
0
0
174
1243
1.44
4.75
3.0
2.9
9.86
10.59
g/l
1.52
159
1141
72
418
1.75
4.75
1.2
1.1
—
—
—
0
0
310
2452
1.32
4.54
1.8
1.9
—
—
—
0
0
71
417
1.73
4.52
1.1
1.1
—
—
—
0
0
23
87
2.67
4.49
1.1
1.1
—
—
—
0
0
157
1113
1.45
4.47
1.5
1.7
—
—
—
0
0
284
2226
1.33
4.43
2.5
2.6
22.84
22.90
%
0.03
267
2072
227
1723
1.37
4.37
4.4
4.7
223.85
247.75
u/l
2.43
218
1640
17
56
3.06
4.24
1.1
1.5
—
62.11
%
—
0
9
235
1802
1.35
4.24
2.7
2.8
5.49
7.70
umol/l
3.23
213
1608
22
84
2.64
4.23
1.7
1.4
40.00
84.44
titre
—
5
9
43
220
1.98
4.23
1.3
1.4
37.52
31.81
u/l
0.39
36
190
78
482
1.65
4.14
1.6
1.4
299.83
290.45
ug/g
0.15
45
292
182
1347
1.39
4.09
2.2
2.1
—
—
—
0
0
29
129
2.27
4.07
1.3
1.7
—
—
—
0
0
167
1220
1.41
4.05
2.1
2.0
—
—
—
0
0
102
677
1.54
4.03
2.0
2.0
41.00
40.11
u/l
0.19
95
604
707
6246
1.22
4.01
4.3
3.7
0.05
0.13
estimate
0.49
132
1412
54
304
1.80
4.00
1.1
1.1
1.29
1.70
u/ml
0.25
30
160
176
1302
1.39
3.97
2.3
2.9
65.67
71.37
e9/l
1.72
137
954
43
228
1.91
3.84
1.1
1.2
2.67
3.95
u/ml
—
9
74
1335
12614
1.26
3.82
24.3
19.3
331.81
331.87
g/l
0.09
1328
12544
36
180
2.02
3.80
1.1
1.1
—
—
—
0
0
62
370
1.70
3.77
1.0
1.1
6.17
5.78
eliau/ml
—
9
49
85
552
1.57
3.71
1.8
2.0
—
—
—
0
0
608
5322
1.22
3.71
3.6
3.2
31.05
31.82
u/l
0.15
572
5027
74
467
1.61
3.65
3.8
4.1
26.53
3.07
ratio
0.46
44
263
77
492
1.59
3.61
1.8
1.9
—
—
—
0
0
42
226
1.88
3.61
1.1
1.2
3.92
5.51
u/ml
0.33
13
96
23
99
2.34
3.51
1.2
1.2
—
—
—
0
0
23
99
2.34
3.51
1.2
1.2
—
—
—
0
0
73
468
1.58
3.39
1.3
1.3
—
—
—
0
0
528
4592
1.22
3.38
4.8
4.0
0.01
0.01
estimate
0.05
156
1634
48
277
1.75
3.32
1.2
1.4
141.77
158.55
au/ml
0.41
13
73
31
156
2.01
3.25
2.7
3.6
13.78
11.38
index
0.88
18
91
79
523
1.53
3.21
3.9
4.4
637.90
63.83
mg/l
0.46
67
458
106
746
1.45
3.20
3.1
2.4
1.14
1.25
%
0.71
106
739
104
730
1.45
3.19
1.5
1.4
—
—
—
0
0
79
524
1.53
3.19
3.9
4.4
29.92
54.92
mg/l
2.12
68
462
239
1917
1.29
3.14
5.6
5.0
33.81
32.62
%
1.03
177
1280
36
195
1.86
3.08
1.3
1.3
0.19
0.28
nmol/l
0.43
26
150
19
80
2.39
3.06
1.3
1.1
—
—
—
0
0
8
16
5.02
3.05
1.0
1.0
—
—
—
0
0
8
16
5.02
3.05
1.0
1.0
—
—
—
0
0
342
2877
1.24
2.99
5.2
4.5
22.74
21.38
%
0.83
153
1402
14
51
2.76
2.98
1.1
1.9
—
—
—
0
0
63
407
1.57
2.88
1.7
1.6
9261.36
11721.99
e6/l
0.31
47
283
149
1136
1.34
2.84
1.2
1.2
85.88
145.14
u/ml
2.21
55
454
46
276
1.68
2.82
1.3
1.2
316.87
270.80
u/ml
0.18
31
159
334
2821
1.23
2.81
1.5
1.5
—
—
—
0
0
45
269
1.69
2.80
1.3
1.3
—
—
—
0
0
45
269
1.69
2.80
1.3
1.3
—
—
—
0
0
139
1056
1.34
2.72
2.3
2.9
114.70
191.48
ng/l
4.07
127
950
27
140
1.94
2.65
1.9
1.8
4.94
7.02
umol/l
0.60
22
95
175
1379
1.30
2.65
3.3
3.3
2.23
1.77
mmol/l
1.20
154
1191
186
1478
1.29
2.65
3.2
2.4
37.60
74.55
u/l
0.58
167
1253
39
228
1.73
2.64
1.0
1.1
—
—
—
0
0
214
1732
1.27
2.63
7.0
8.6
1.46
0.94
mmol/l
1.06
175
1444
615
5525
1.18
2.62
3.5
3.4
7.81
7.31
mmol/l
1.88
521
4700
164
1287
1.30
2.57
2.6
3.2
66.80
66.72
g/l
0.05
152
1195
18
81
2.24
2.54
2.6
3.0
585.11
1376.22
u/ml
1.57
18
81
414
3605
1.20
2.53
6.4
5.4
1.81
2.67
ug/l
2.14
379
3267
31
172
1.82
2.51
1.7
2.3
47.50
20.31
mg/l
—
8
62
223
1825
1.25
2.51
1.8
1.7
—
—
—
0
0
11
37
2.99
2.49
1.0
1.1
—
—
—
0
0
180
1438
1.28
2.47
3.3
3.2
5.95
5.79
kpa
1.30
173
1396
152
1188
1.31
2.46
3.0
2.7
4.53
4.58
kpa
0.09
146
1151
61
407
1.52
2.46
2.8
2.0
1946.97
6227.35
u/l
1.40
25
172
66
449
1.49
2.43
1.4
1.3
—
—
—
0
0
214
1755
1.25
2.37
7.1
8.6
5.14
5.12
kpa
0.07
207
1691
214
1755
1.25
2.37
7.1
8.6
13.25
12.49
kpa
1.01
207
1692
212
1738
1.25
2.35
1.8
1.8
—
—
—
0
0
261
2192
1.22
2.32
3.3
3.2
0.73
0.75
ug/l
0.09
166
1418
66
457
1.46
2.25
1.8
2.1
2.42
16.56
iu/l
0.60
23
188
10
35
2.87
2.21
1.0
1.1
—
—
—
0
0
104
785
1.35
2.17
2.6
3.4
1.48
1.67
mmol/l
0.23
70
583
10
36
2.79
2.14
1.0
1.0
—
—
—
0
0
10
36
2.79
2.14
1.0
1.0
—
—
—
0
0
12
49
2.46
2.10
1.3
1.2
—
—
—
0
0
27
153
1.78
2.08
2.2
4.0
52.26
56.09
%
0.40
19
136
9
31
2.91
2.07
1.0
1.1
—
—
—
0
0
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
16
76
2.12
2.02
1.0
1.1
1658.56
1546.50
miu/ml
0.12
16
76
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
18
91
1.99
1.95
2.7
3.9
0.94
0.91
index
0.07
18
91
66
472
1.41
1.94
1.3
1.3
233.25
218.47
miu/ml
0.11
31
226
69
498
1.40
1.92
3.0
3.6
24.85
24.71
mmol/l
0.16
60
463
96
731
1.33
1.92
1.5
1.4
—
—
—
0
0
35
543
0.64
1.91
1.1
1.2
1.47
1.57
g/l
1.70
35
543
19
99
1.93
1.90
1.6
2.2
18.42
19.89
nmol/l
0.24
19
93
67
483
1.40
1.89
1.5
1.5
0.18
0.08
iu/ml
0.55
15
74
21
114
1.85
1.87
1.0
1.1
7.96
10.88
iu/ml
—
5
34
130
1036
1.28
1.87
3.1
3.5
4.39
4.49
pmol/l
0.82
117
923
62
442
1.42
1.86
3.5
3.0
0.00
0.00
g/l
-0.00
57
417
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
188
1567
1.22
1.83
7.6
9.1
96.56
95.72
%
1.32
181
1516
15
73
2.06
1.80
1.4
1.3
203.67
165.55
pmol/l
0.67
15
73
18
94
1.92
1.80
1.3
1.7
97.17
109.85
ng/l
0.43
18
94
39
255
1.54
1.79
1.1
1.1
0.85
3.39
u/ml
3.55
16
124
67
488
1.39
1.79
3.4
2.9
0.04
0.00
g/l
0.45
61
441
100
775
1.31
1.79
2.1
2.0
—
—
—
0
0
31
192
1.63
1.78
1.2
1.4
—
—
—
0
0
26
154
1.70
1.76
3.0
4.4
—
—
—
0
0
130
1045
1.26
1.76
9.4
10.5
94.81
93.87
%
1.69
130
1040
31
193
1.62
1.75
1.2
1.5
—
—
—
0
0
31
193
1.62
1.75
1.2
1.5
—
—
—
0
0
6
18
3.34
1.74
1.0
1.0
0.10
7.72
u/ml
—
6
18
65
474
1.39
1.73
3.5
3.0
0.00
0.00
g/l
-0.00
57
417
51
356
1.45
1.73
1.5
1.6
—
—
—
0
0
85
648
1.33
1.72
1.9
1.8
—
—
—
0
0
38
561
0.67
1.67
1.1
1.2
0.89
0.90
g/l
0.10
38
561
63
461
1.38
1.66
1.4
1.3
—
—
—
0
0
117
938
1.27
1.63
2.9
3.5
5.04
5.13
kpa
0.79
110
912
128
1039
1.25
1.61
9.4
10.4
1.31
1.31
%
0.01
128
1032
75
569
1.33
1.58
1.8
1.5
—
—
—
0
0
75
571
1.33
1.55
3.6
3.1
0.46
1.16
g/l
1.87
67
499
28
176
1.60
1.55
1.1
1.2
—
—
—
0
0
57
416
1.38
1.54
1.2
1.1
5.10
3.87
—
5
56
14
71
1.98
1.54
1.2
1.3
182.57
438.35
u/l
1.03
14
66
34
501
0.67
1.51
1.1
1.1
0.78
0.64
ratio
—
5
62
80
619
1.31
1.49
3.5
2.9
2.85
2.93
g/l
0.30
72
569
236
2052
1.17
1.48
5.0
5.9
1.01
1.04
mmol/l
1.16
216
1909
7
28
2.51
1.45
1.1
1.4
—
—
—
0
0
5
16
3.13
1.44
1.0
1.1
3.04
5.42
nmol/l
—
5
16
13
66
1.98
1.43
1.2
1.0
—
—
—
0
0
72
553
1.32
1.42
3.1
3.0
9.94
10.48
g/l
0.60
63
498
83
651
1.29
1.41
3.4
2.8
6.97
7.43
g/l
1.47
75
601
83
651
1.29
1.41
3.4
2.8
4.01
4.27
g/l
2.63
75
601
83
651
1.29
1.41
3.4
2.8
3.58
3.71
g/l
0.32
75
601
1311
12716
1.13
1.37
21.6
18.7
13.54
13.61
%
1.19
1296
12533
17
97
1.76
1.35
1.8
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
61
1.97
1.33
1.1
1.1
—
—
—
0
0
92
742
1.25
1.27
3.7
3.2
1.02
1.02
ratio
0.20
83
673
17
99
1.72
1.27
1.1
1.4
2.46
2.24
mmol/l
0.12
17
92
28
186
1.51
1.26
1.3
1.5
—
—
—
0
0
28
186
1.51
1.26
1.3
1.5
—
—
—
0
0
9
45
2.01
1.23
1.0
1.5
8.46
9.55
ug/l
—
9
45
24
155
1.56
1.23
2.4
1.5
—
—
—
0
0
10
49
2.05
1.22
1.0
1.0
—
—
—
0
0
74
585
1.28
1.22
1.4
1.7
0.20
0.34
mg/l
2.51
26
271
28
188
1.50
1.21
1.3
1.5
—
—
—
0
0
45
333
1.36
1.17
4.9
5.8
98.50
396.58
iu/ml
—
6
45
8
39
2.06
1.15
1.3
1.1
—
—
—
0
0
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
21
134
1.57
1.14
1.1
1.3
—
—
—
0
0
11
58
1.90
1.12
1.0
1.1
—
—
—
0
0
10
51
1.97
1.11
2.8
1.6
—
—
—
0
0
13
73
1.79
1.11
1.1
1.1
1.05
1.05
ratio
0.07
13
60
55
425
1.30
1.09
1.5
1.3
—
—
—
0
0
568
5324
1.10
1.09
4.2
4.1
5.58
8.64
mg/mmol
1.28
345
3263
20
128
1.57
1.08
1.1
1.0
—
—
—
0
0
43
321
1.35
1.08
1.7
1.5
—
—
—
0
0
34
244
1.40
1.08
2.9
3.7
2.35
1.67
%
0.26
26
224
55
427
1.30
1.06
1.3
1.3
—
—
—
0
0
26
179
1.46
1.03
1.3
1.6
50.54
60.31
%
0.55
18
115
9
47
1.92
1.02
1.0
1.7
146.44
88.85
nmol/24h
—
9
47
16
99
1.62
1.00
2.3
1.7
—
—
—
0
0
9
157
0.57
0.98
1.4
1.5
64.27
56.46
ug/l
—
9
157
46
353
1.31
0.98
2.0
2.3
130.85
129.37
g/l
0.17
34
279
25
173
1.45
0.97
1.9
1.6
26.03
29.48
ng/l
0.14
25
173
11
186
0.59
0.96
1.7
1.7
—
—
—
0
0
9
51
1.77
0.94
2.8
2.3
58.67
50.96
umol/l
—
9
46
7
37
1.90
0.94
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
27
2.23
0.93
1.0
1.3
—
80.86
—
0
7
39
295
1.33
0.93
3.6
8.6
106.32
105.05
mmol/l
1.21
34
259
61
491
1.25
0.92
4.2
3.8
1.19
1.35
mmol/l
0.76
61
485
13
78
1.67
0.91
1.3
1.7
—
—
—
0
0
6
28
2.15
0.91
1.3
1.1
—
—
—
0
0
15
95
1.58
0.87
2.3
3.8
85.87
316.48
nmol/l
0.53
15
95
80
672
1.20
0.83
1.7
1.9
1.55
1.57
g/l
0.06
75
591
34
258
1.32
0.81
2.3
3.1
—
2229.30
—
0
23
15
97
1.55
0.81
1.0
1.3
27.13
24.89
umol/l
0.10
15
89
14
89
1.58
0.81
1.1
1.2
—
—
—
0
0
175
1569
1.13
0.79
2.3
2.3
0.23
0.21
g/l
2.43
164
1479
13
82
1.59
0.78
1.2
1.1
—
—
—
0
0
74
622
1.20
0.77
1.6
1.7
2.53
4.86
mg/l
1.48
58
450
11
67
1.65
0.75
5.2
1.7
—
—
—
0
0
11
67
1.65
0.75
1.0
1.3
2.14
2.15
umol/l
0.01
11
57
35
271
1.30
0.74
1.1
1.2
—
490.00
—
0
6
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
27
202
1.34
0.72
1.1
1.1
—
—
—
0
0
12
76
1.58
0.71
1.2
1.5
—
—
—
0
0
12
76
1.58
0.71
1.2
1.5
—
—
—
0
0
27
354
0.76
0.70
1.9
2.5
94.33
136.87
ug/min
0.26
16
217
20
143
1.40
0.70
1.2
1.2
—
—
—
0
0
18
127
1.42
0.68
1.3
1.1
101.28
109.22
pmol/l
0.29
18
127
15
102
1.47
0.67
1.4
1.4
70.07
78.91
umol/l
1.25
15
102
15
214
0.70
0.66
1.7
1.6
—
—
—
0
0
5
28
1.79
0.66
2.6
1.8
0.50
0.50
e9/l
—
5
28
5
28
1.79
0.66
1.0
2.4
—
19910.00
—
0
5
30
234
1.29
0.63
1.8
1.4
0.18
0.33
nmol/l
3.11
25
182
6
102
0.59
0.62
1.2
1.2
7.17
10.19
u/l
—
6
91
10
63
1.59
0.61
1.2
1.4
—
—
—
0
0
10
63
1.59
0.61
1.2
1.4
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
24
309
0.77
0.57
1.1
1.4
—
—
—
0
0
16
115
1.39
0.56
2.5
2.4
37.50
33.10
mg/l
—
10
80
25
319
0.78
0.56
3.9
3.7
33.49
23.46
mg/l
0.91
17
229
36
438
0.82
0.54
1.7
1.6
1084.94
982.21
mu/l
0.26
28
366
24
186
1.29
0.54
1.0
1.0
0.01
0.28
u/ml
—
6
59
12
82
1.47
0.54
1.2
1.4
—
—
—
0
0
14
99
1.42
0.54
1.4
1.9
—
—
—
0
0
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
6
39
1.54
0.53
1.0
1.2
171.17
295.62
pmol/l
—
6
26
12
83
1.45
0.51
1.2
1.4
—
—
—
0
0
9
65
1.39
0.50
1.1
1.1
120.04
237.80
iu/ml
—
9
65
156
1695
0.91
0.50
2.0
2.1
3.40
3.43
ratio
0.13
123
1335
11
156
0.70
0.50
1.3
1.8
—
—
—
0
0
34
280
1.22
0.49
1.1
1.1
9.38
17.68
au/ml
—
5
71
10
68
1.47
0.47
2.4
2.5
23.73
135.30
ug/l
—
10
60
7
48
1.46
0.46
1.1
1.4
—
—
—
0
0
187
1740
1.08
0.46
4.0
4.6
10.62
23.22
ug/l
0.94
161
1420
8
58
1.38
0.41
1.9
2.4
—
—
—
0
0
29
240
1.21
0.41
1.1
1.1
0.45
1.80
u/ml
1.51
16
117
52
454
1.15
0.41
1.3
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
29.00
—
0
9
36
423
0.85
0.41
1.6
1.6
—
—
—
0
0
11
79
1.39
0.40
1.5
1.2
9.73
10.13
mm/h
0.04
11
79
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
13
171
0.76
0.39
1.2
1.4
3061.50
1840.41
e6/l
—
8
114
18
142
1.27
0.38
1.8
1.7
—
—
—
0
0
11
80
1.38
0.38
1.1
1.2
—
—
—
0
0
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
26
216
1.21
0.37
1.0
1.1
3.52
2.59
u/ml
0.17
13
92
25
207
1.21
0.36
1.0
1.1
1.62
2.83
eliau/ml
0.62
14
94
149
1593
0.93
0.36
2.8
3.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
451
1.13
0.35
2.6
2.8
0.38
0.36
iu/ml
0.16
22
240
9
124
0.72
0.35
1.4
1.6
—
—
—
0
0
10
73
1.37
0.34
1.1
1.2
31.94
31.45
umol/l
—
10
65
6
44
1.36
0.34
1.0
1.2
—
—
—
0
0
19
154
1.24
0.34
1.6
1.3
414132.86
86948.26
e6/l
0.48
14
103
13
100
1.30
0.33
1.2
1.4
2.22
1.20
promille
—
7
81
30
346
0.86
0.30
2.9
2.6
1.20
1.57
mmol/l
3.87
30
333
25
292
0.85
0.29
1.4
1.4
—
—
—
0
0
8
62
1.29
0.28
2.9
4.2
—
—
—
0
0
13
161
0.81
0.27
1.2
1.4
1.32
1.36
nmol/l
0.05
13
144
5
72
0.69
0.26
1.4
2.5
1.80
1.31
%
—
5
72
16
132
1.21
0.25
1.1
1.3
1.85
0.89
u/ml
0.23
11
66
11
138
0.80
0.25
1.3
1.6
—
—
—
0
0
11
138
0.80
0.25
1.3
1.6
—
—
—
0
0
11
138
0.80
0.25
1.3
1.6
—
—
—
0
0
119
1259
0.94
0.24
1.8
1.8
3.45
3.52
mmol/l
0.27
88
900
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
26
227
1.15
0.24
1.3
1.5
—
—
—
0
0
25
285
0.88
0.23
1.6
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
7.60
—
0
10
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
16.15
—
0
13
454
4441
1.03
0.20
3.3
3.4
0.09
0.23
estimate
0.31
138
1359
68
635
1.07
0.20
1.2
1.4
—
—
—
0
0
12
144
0.83
0.20
1.2
1.4
6610.00
158841.13
e6/l
—
6
76
6
50
1.20
0.19
1.7
2.7
0.63
0.61
mmol/l
—
6
50
6
51
1.18
0.19
3.3
3.1
24.75
29.96
umol/l
—
6
37
7
58
1.21
0.18
1.7
1.6
—
—
—
0
0
56
522
1.08
0.18
2.4
2.7
—
—
—
0
0
23
205
1.12
0.17
1.1
1.1
—
—
—
0
0
12
141
0.85
0.16
2.2
2.9
—
—
—
0
0
36
332
1.09
0.15
1.5
1.6
—
—
—
0
0
38
410
0.93
0.15
1.5
1.6
—
—
—
0
0
26
286
0.91
0.15
2.8
2.6
6.74
7.69
mmol/l
1.77
26
274
120
1247
0.96
0.15
3.0
4.1
1.23
1.23
mmol/l
0.41
103
1080
9
81
1.11
0.15
1.1
1.8
—
—
—
0
0
9
81
1.11
0.15
1.1
1.8
—
—
—
0
0
9
81
1.11
0.15
1.1
1.8
—
—
—
0
0
9
81
1.11
0.15
1.1
1.8
—
—
—
0
0
33
305
1.08
0.13
1.3
1.4
—
—
—
0
0
23
253
0.91
0.13
1.1
1.4
—
—
—
0
0
18
200
0.90
0.12
1.9
2.6
32.17
32.39
pg
0.08
18
200
22
200
1.10
0.12
1.7
1.7
—
—
—
0
0
40
425
0.94
0.11
1.5
1.7
—
—
—
0
0
31
289
1.07
0.11
2.2
3.1
41.69
35.67
umol/l
0.31
26
263
13
115
1.13
0.10
1.3
1.3
—
—
—
0
0
5
47
1.06
0.09
1.0
1.6
14.40
13.96
pmol/l
—
5
40
14
155
0.90
0.09
5.4
4.9
51.87
50.55
u/ml
—
6
50
19
206
0.92
0.08
1.7
1.6
—
—
—
0
0
5
63
0.79
0.08
1.2
1.9
—
—
—
0
0
5
63
0.79
0.08
1.2
1.9
—
—
—
0
0
5
63
0.79
0.08
1.2
1.9
—
—
—
0
0
17
156
1.09
0.08
1.1
1.2
—
—
—
0
0
50
485
1.03
0.05
3.1
3.3
1.48
1.55
mg/l
0.21
44
447
25
238
1.05
0.05
1.6
1.5
—
—
—
0
0
64
627
1.02
0.03
3.0
3.8
1016.58
2496.71
u/ml
0.41
57
546
60
612
0.98
0.03
1.7
2.0
4.22
1.31
ug/l
0.56
51
549
37
360
1.03
0.03
1.3
1.5
—
—
—
0
0
25
241
1.04
0.02
1.7
1.5
0.91
0.93
ratio
0.10
15
149
25
241
1.04
0.02
1.7
1.5
1.00
1.26
ratio
1.73
15
149
25
241
1.04
0.02
1.7
1.5
1.57
1.09
ratio
0.99
15
149
10
107
0.93
0.02
1.2
1.5
—
—
—
0
0
11
116
0.95
0.00
1.8
1.2
—
—
—
0
0
15
151
0.99
0.00
2.7
6.2
10.13
7.25
mmol/l
—
10
124
17
171
0.99
0.00
1.8
2.2
-0.40
0.40
mmol/l
0.39
17
166
35
345
1.01
0.00
2.7
3.8
61.98
1250.15
u/ml
0.95
29
321
17
168
1.01
0.00
1.2
1.7
—
—
—
0
0
10
97
1.03
0.00
6.8
6.5
0.72
198.31
ug/l
—
5
60
14
137
1.02
0.00
1.5
2.4
1144.43
1033.89
mg
0.11
14
137
26
257
1.01
0.00
1.7
1.6
77.16
58.96
ug/l
0.81
19
212
29
293
0.99
0.00
4.1
3.5
0.69
0.80
nmol/l
1.49
24
241
0
8
0.00
0.00
0.0
1.6
—
29.96
—
0
8
5
51
0.98
0.00
1.8
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
2.38
—
0
8
0
6
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
4.7
1.8
40.34
40.63
g/l
—
7
71
6
63
0.95
-0.00
1.2
2.7
—
55568.25
—
0
8
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
99
0.91
-0.00
1.2
1.5
—
—
—
0
0
9
96
0.94
-0.00
1.2
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
64
0.94
-0.00
10.2
11.6
0.66
0.64
mmol/l
—
6
57
0
5
0.00
-0.00
0.0
5.2
—
398.20
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_DISTU_SMELL_TASTE – Disturbances of smell and taste
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).